Potential Mechanisms Linking Food-Derived MicroRNAs, Gut Microbiota and Intestinal Barrier Functions in the Context of Nutrition and Human Health

MicroRNAs (miRNAs) are non-coding single-stranded RNA molecules from 18 to 24 nucleotides that are produced by prokaryote and eukaryote organisms, which play a crucial role in regulating gene expression through binding to their mRNA targets. MiRNAs have acquired special attention for their potential in cross kingdom communication, notably food-derived microRNAs (xenomiRs), which could have an impact on microorganism and mammal physiology. In this review, we mainly aim to deal with new perspectives on: (1) The mechanism by which food-derived xenomiRs (mainly dietary plant xenomiRs) could be incorporated into humans through diet, in a free form, associated with proteins or encapsulated in exosome-like nanoparticles. (2) The impact of dietary plant-derived miRNAs in modulating gut microbiota composition, which in turn, could regulate intestinal barrier permeability and therefore, affect dietary metabolite, postbiotics or food-derived miRNAs uptake efficiency. Individual gut microbiota signature/composition could be also involved in xenomiR uptake efficiency through several mechanisms such us increasing the bioavailability of exosome-like nanoparticles miRNAs. (3) Gut microbiota dysbiosis has been proposed to contribute to disease development by affecting gut epithelial barrier permeability. For his reason, the availability and uptake of dietary plant xenomiRs might depend, among other factors, on this microbiota-related permeability of the intestine. We hypothesize and critically review that xenomiRs-microbiota interaction, which has been scarcely explored yet, could contribute to explain, at least in part, the current disparity of evidences found dealing with dietary miRNA uptake and function in humans. Furthermore, dietary plant xenomiRs could be involved in the establishment of the multiple gut microenvironments, in which microorganism would adapt in order to optimize the resources and thrive in them. Additionally, a particular xenomiR could preferentially accumulate in a specific region of the gastrointestinal tract and participate in the selection and functions of specific gut microbial communities.

Introduction

MicroRNAs (miRNAs/miRs) are small single-stranded non-coding RNA molecules of ~24 nucleotides in length, discovered in Caenorhabditis elegans in 1993 (1, 2). MiRNAs play a key role in post-transcriptional gene expression regulation by their base complementary binding to mRNAs, which promote mRNA degradation or suppress translation (1, 3). MiRNAs participate in several biological functions in animals, such as metabolism (4), immune system development and immune responses (5), proliferation, cell death, differentiation (6) or embryogenesis (7). In plants, miRNAs are attributed a role in processes such as plant development (8) stress responses (9), metabolism or cell signaling (10, 11). Of note, mature plant miRNAs are characterized by a methylation in the 3-terminal nucleotide 2-hydroxyl group, which increases stability by protecting miRNAs from exonuclease degradation (12, 13). In vascular plants, RNA molecules, including miRNAs, could be transferred locally between cells and over long-distances, by the plasmodesmata and the phloem vasculature, which suggest a role for RNA molecules in transmitting information beyond their cell of synthesis (influencing processes such as stress responses or development) (14–16).

Indeed, plant miRNAs have gained special attention in recent years for their potential role as cross-kingdom gene expression regulators, influencing plant interactions with animals and microorganisms, which has been discussed in a number of reports (17–19). Thus, plant miRNAs have been extensively studied for their involvement in plant-microorganism interactions, influencing processes like the arm race co-evolution between host and parasites (20, 21). In animals, diet would be a primary source of phase plant miRNA uptake, subsequently being detected in fluids and tissues of a wide range of species such as mice (22), pigs (23) and humans (24), whereby have been termed as xeno-miRNAs (xenomiRs). The mechanisms through which xenomiRs would penetrate into the bloodstream to eventually reach animal tissues and organs have been reviewed by several authors (17, 25, 26). To sum up,

1) it has been suggested that xenomiRs could be taken up by intestinal epithelial cells through molecules such as transmembrane miRNA carriers or receptor-facilitated endocytosis (17, 25, 26).

2) Alternatively, extracellular vesicles could be incorporated in mammalian cells through mechanism such as phagocytosis, macropinocytosis, clathrin-mediated, caveolin-mediated, and clathrin and caveolin-independent endocytosis (27). Even though the mechanism by which plant extracellular vesicles could be internalized into intestinal epithelial cells is not well-know yet, for example, it has been demonstrated that exosome-like nanoparticles, which contained miRNA, could be incorporated in intestinal epithelial stem cells by micropinocytosis (28).

3) Once xenomiRs are inside intestinal epithelial cells, they could be packaged into microvesicles, which appears to be the main form of transport for at least certain types of xenomiRs, to subsequently be released into the bloodstream (23, 24, 29, 30).

4) Another xenomiR bloodstream transportation mechanism consists in xenomiR association with proteinase K-resistant complexes during digestion or absorption, which has been identified for miR-2911 (31).

5) It has also been postulated that immune system cells could contribute to the xenomiR cross-kingdom transfer by capturing them in the intestinal lumen and releasing them into the bloodstream (25).

6) In addition, it has been suggested that xenomiRs could diffuse paracellularly between gut barrier intercellular spaces (17).

In prokaryotes, in particular bacteria, several small non-coding RNAs (snRNAs) from 50 to 200 nucleotides with post-transcriptional regulatory functions have been also identified. These prokaryotic snRNAs affect bacterial physiology by modulating many processes, such as microorganism virulence and communication, metabolism or stress response (32, 33). A wide range of those snRNAs exert their post-transcriptional effects through base complementary binding to mRNAs targets, being considered functional analogs to eukaryotic miRNAs (32, 34). However, these prokaryotic snRNAs present many differences with eukaryotic miRNAs, regarding their biogenesis, their mRNA binding site, the presentation to mRNA target and/or their mechanism of action, since they can inhibit or enhance mRNA translation, meanwhile eukaryotic miRNAs classically down-regulate gene expression (35, 36). Notably, a subtype of prokaryotic snRNA of similar size to eukaryotic miRNAs has been recently identified. This newly identified snRNA has received several denominations, such as micro-like size sRNAs or microRNA-like molecules, being thus considered as typical miRNAs (35, 37, 38). Indeed, it has been reported that prokaryotic microRNA-like molecules could play an important role as virulence factors (39, 40). For instance, Gu et al. (40) showed that Salmonella could take advantage of the machinery of human intestinal epithelial cells to produce microRNA-like molecules as virulence factors, thus promoting bacteria survival and proliferation in mice.

On the other hand, the influence of diet on microbiota composition has been extensively investigated and documented (41–43). Gut microbiota is involved in essential functions for host physiology such as metabolism (through, for example, the fermentation of indigestible carbohydrates and the production of metabolites important for organism homeostasis maintenance) (44, 45), immune system development and function (46), protection against pathogen colonization (47) or intestinal barrier shaping, been involved in their development, reparation and integrity and functionality maintenance (48–51). Additionally, a large number of studies reported that host-derived miRNAs could shape gut microbiota composition through modulation of expression of genes that affect microbe growth (52, 53). In turn, gut microbiota could regulate miRNA expression of host cells, such as intestinal epithelial cells (54–56). Furthermore, some authors pointed out that the bidirectional interaction between host miRNAs and gut microbiota could have an impact on intestinal permeability (52, 54). However, although host fecal miRNAs can modulate the microbiome (53), the role of non-absorbed dietary xenomiRs on microbiota composition modulation by regulating gene expression is scarcely known. Interestingly, it has been postulated that prokaryotic miRNA-like molecules could have an important role in cross-kingdom gene expression regulation, which has been proposed by several authors (35, 57). For example, Shmaryahu et al. (58) predicted pathogenic-bacteria miRNAs that may potentially regulate the expression of human genes involved in several diseases such as diabetes, colon cancer or leukemia. In fact, the authors demonstrated that the prokaryotic miRNAs could down-regulate target gene expression in human cells. The studies carried out by Choi et al. (39) revealed that prokaryotic miRNA-size molecules secreted by periodontal pathogens in vesicles, could enter human cells and down-regulate cytokine expression. However, most of the documented cases of cross-kingdom communication mediated by prokaryote miRNA-like molecules usually refer to pathogenic bacteria and an interaction between non-pathogenic bacteria, such as microbiota, and host cells, mediated by prokaryotic miRNA-like molecules is not well-known. Even so, it has been postulated that not only host miRNAs, but also prokaryotic miRNA-like molecules could also be involved in microbiota-host communication (59, 60). Indeed, and due to the lack of solid evidences regarding the influence of prokaryotic snRNAs, particularly miRNA-like molecules in human physiology, they are out of the scope of the current review.

In this review, we ought to provide new insights on the potential role of the gut microbiota influencing dietary plant xenomiR absorption and to summarize the evidences provided so far regarding the impact that the crosstalk between diet, gut microbiota and mammalian cells could exert on xenomiR absorption/uptake.

Lack of Consensus on Dietary Xenomir Hypothesis and Potential Explanatory Factors

One of the potential fates of plant-derived xenomiRs incorporated through diet, once they have reached the gastrointestinal tract, is to penetrate into the bloodstream and eventually, to exert a regulation of the expression of target genes in several tissues and organs. However, the specific mechanisms involved in this hypothesis are, to date, still unclear.

Zhang et al. in 2011 (29) reported the presence of rice (Oryza sativa) miR-168a in the serum from humans and other animals. This xenomiR could inhibit the expression of the low-density lipoprotein receptor adapter protein 1 (LDLRAP1) in mouse liver, with physiological consequences in the organism, such as the increase of LDL in plasma. After this pioneer study, numerous publications have continued to report the presence of xenomiRs from diverse plants in the serum and tissues of mammals, including humans (22–24, 61, 62). Mlotshwa et al. (63) revealed that oral administered synthetic miR-34a, miR-143 and miR-145, which mimic the characteristics of plant miRNAs, were capable of displaying anti-tumor properties, thus preventing the development and lessen colon cancer progression in mice. Furthermore, Zho et al. (30) discovered that honeysuckle (Lonicera japonica) miR-2911, once it had crossed the gastrointestinal barrier and reached the lungs, was able to repress PB2 and NS1 mRNA expression, which encode for two proteins essential for H1N1 Influenza A virus replication, diminishing mortality rate in mice fed with honeysuckle. Subsequently, Chin et al. (64) detected plant miR-159 in human serum and tissues. Their data revealed that, upon oral uptake of synthetic miR-159, TCF7 gene expression was inhibited, resulting in repression of breast cancer tumor growth in mice. Recent studies are still providing data about the relevance of inter-species gene regulation by plant xenomiRs. Thus, Du et al. (65) showed that Rhodiola crenulata small RNA HJT-sRNA-m7 can reach the lungs via intratracheally administration and down-regulate the expression of genes involved in pulmonary fibrosis development in mice, which could culminate in the amelioration of the disease. Moreover, Svecia et al. (66) detected an increase in plant xenomiR levels in the plasma of humans who had taken Tuscany Sangiovese grape juice. They also revealed that, in mice, Tuscany Sangiovese miRNAs appeared to play a cardioprotective role maintaining the functionality of hearts that had suffered a myocardial infarction.

Despite the huge amount of emerging evidences of the capacity of plant miRNAs from food to be absorbed, travel through the bloodstream and modulate the expression of target genes in mammals, several studies do not fully support the xenomiR cross-kingdom regulation hypothesis due to the inability to detect xenomiRs in serum or tissues. In fact, Zhang et al. (67) questioned technical/methodological issues affecting miRNA detection in publically available databases and alleged that dietary plant miRNAs present in some databases of animal small RNAs could be cross-contaminations during sequencing processes. Some supportive and refuting evidences of the cross-kingdom regulation dietary xenomiR hypothesis have been summarized in Table 1 and have been also extensively summarized by other works (17).

TABLE 1

Table 1. Some evidences for and against the detection of plant-derived xenomiRs on mammalian fluids and organs.

One of the first studies that cast doubt on cross-kingdom uptake of xenomiRs was conducted by Dickinson et al. (68), who unsuccessfully tried to reproduce Zhang's results (29). These authors observed that xenomiRs levels in mouse plasma and liver after ingestion of rice chow were negligible. They also did not detect any change in LDLRAP1 expression in liver, even though LDL levels were increased. So, they postulated that the result obtained by Zhang et al. (29) could arise from sequencing errors, cross-contamination or the use of little sensitive and specific techniques, while the increase in plasma LDL could be a consequence of the impact of diet and not of the xenomiR gene expression modulation (68). However, although their data were controversial, Zhang et al. (29) did not retract their findings, so far.

Afterwards, Snow et al. (69) published a study in which xenomiRs were not detected in the plasma of healthy humans and mice that had been fed with a diet enriched in certain plant miRNAs. On the contrary, Witwer et al. (70) were able to detect a low amount of plant xenomiRs in plasma of macaques fed with plant miRNAs-rich substances, but they concluded that this relatively low xenomiR circulating levels could have been originated in a non-specific amplification. Later, Pastrello et al. (73, 74) retracted their report in which they detected miRNAs from broccoli (Brassica oleracea) in the serum of human subjects who had consumed this vegetable, alleging errors in primers design. In the experiments performed by Huang et al. (71) no significant differences were detected in either serum or tissues of mice that had been fed with chow diet supplemented with corn miRNAs. In light of these findings, they suggested that most part of xenomiRs might have been degraded during digestive process and the minimal amount of xenomiRs that could prevail and reach tissues would be insufficient to modulate the expression of endogenous host genes and cause physiological changes. Finally, Micó et al. (72) reported an increase of extra virgin olive oil miRNAs in the plasma of healthy humans but they considered that the negligible levels detected were artifacts resulted from cross-contamination. Analysis of plant miRNAs in human sequencing databases has led many authors to suggest that the underlying causes of xenomiR detection in mammal's body fluids and tissues would be technical artifacts due to cross-contamination during library preparation. The authors conclude that the abundance of xenomiRs in human tissues and fluids would be negligible and there would not be significant differences in terms of xenomiR levels in tissues exposed to food intake, such as the liver, compared to those that have no direct relationship with, like the cerebrospinal fluid (75, 76). Another study demonstrated that miRNA purification columns themselves could be a capture focus for exogenous miRNAs with an unknown origin, many of which appear reflected in human miRNA sequencing databases (77).

Efforts to explain the disparity of evidences for and against xenomiR hypothesis continue monopolizing the core of many investigations. It seems obvious that technical factors such as cross-contaminations, miRNAs purification methods, xenomiR degradation during digestion, and errors during sequencing processes (primer design and non-specific sequencing), could throw into question many of the studies that suggest that xenomiRs could modulate gene expression among different species and kingdoms. Nevertheless, recent reports such as the published by Zhao et al. (78) highlight the need to continue researching in this area and open the door to the exploration of other factors that could shed light and clarify the xenomiRs-host transfer hypothesis. After analyzing an enormous amount of small RNA sequencing data in public databases, Zhao et al. (78) reported that plant miRNAs could reach human fluids and tissues. Unlike previous studies, a remarkably thorough filtering of the sequencing reads was achieved in order to avoid any type of false positives, and cross-contamination was also strongly ruled out (78).

In this way, Zhao et al. (79) recently suggested that one of the factors that could explain the lack of detection of plant miRNAs in animals by certain studies would be the miRNA sequence. Thus, the authors pointed out that not all plant miRNAs could be absorbed, but it would take place a selective absorption reliant on the sequence, in which the high GC content, the shorten length and the motif “CAG” would be determinant in promoting xenomiR uptake (79). Another potential explanatory factor of the variance of xenomiR detection could be intestinal barrier permeability, which will be addressed in the following section.

Potential Role of Gut Microbiota in the Uptake of Xenomirs in Mammals by Modulating Intestinal Barrier Permeability

Concerning current evidences, we propose that differences in the absorption of plant miRNAs between subjects could be an important factor that could explain, at least in part, the observed variability in the detection of plant miRNAs in mammalian plasma and tissues among different research groups. The permeability of the intestinal barrier could play a major role in the absorption efficiency of xenomiRs and further exploration of its potential role is required. In support of this notion, the studies of Raoof et al. (80) showed an increase of antisense oligonucleotide plasma levels when the epithelial intestinal barrier is leakier. The co-administration of phosphorothioate antisense oligonucleotide ISIS 104838 drug and the permeation enhancer sodium caprate, which promotes changes in intestinal barrier permeability, improved the bioavailability of the drug in dog blood (80, 81). In this context, Yang et al. (61) suggested that the alteration of gastrointestinal barrier permeability could enhance xenomiR uptake and entry to the bloodstream. They observed an increase in diet miRNAs in the bloodstream of mice who had their intestinal barrier integrity altered with cisplatin, suggesting that xenomiR uptake could be enhanced during certain pathologies or chemotherapeutic treatments that alter intestinal barrier integrity (61). Recently, Yang et al. (82) generated mouse models that displayed increased intestinal permeability through the administration of aspirin or anti-CD3 antibodies. In these models, plant-based small RNA uptake was higher as compared to controls. However, their data pointed out that changes in intestinal permeability could only have a significant impact on the absorption of the more stable small RNAs, since the less digestion-resistant RNAs would be degraded (82). Nevertheless, although modulation of intestinal permeability by itself could not have a relevant impact on the bioavailability of the most degradation-sensitive xenomiRs during cooking or digestion, we propose that it could entail special relevance in those cases where xenomiRs were transported in exosome-like extracellular vesicles, since they could be highly resistant to degradation (83, 84) (this issue is further developed and more widely documented in the following section) (section Involvement of Gut Microbiota in Release of Plant miRNAs From Extracellular Vesicles).

Recent studies have highlighted that microbiota could play a key role in maintaining integrity and functionality of intestinal barrier in physiological conditions and during adult lifelong, since it would be involved in determining paracellular permeability through mechanisms such as expression modulation of proteins that are part of tight junctions. Compared to controls, germ-free mice displayed lower paracellular permeability, and transplantation of fecal microbiota from healthy humans led to restoration of paracellular permeability up to levels considered normal, through the decrease of claudin-1 expression and the transient IL-18 production by enterocytes (85).

For this reason, we hypothesize that it would be possible that specific gut microbes could have different effects on intestinal barrier integrity in such a way that a given microorganism could increase permeability while others could be involved in its decrease or have any effect. Thus, there could be an inherent variability as regards of intestinal barrier permeability among different subjects that could depend on the specific composition of gut microbiota. In support of this hypothesis, several authors have reported that colonization of germ-free mice with Bacteroides thetaiotaomicron or Escherichia coli Nissle 1917 (EcN) led to up-regulation of genes that encode for proteins involved in maintaining adhesion between intestinal epithelial cells, such as small proline-rich protein-2 (sprr2a) and zonula occludens-1 (ZO-1), respectively, which for EcN was proved to result in decreased intestinal permeability when colitis mouse model was treated with this bacterium (86, 87). By contrast, other bacteria such as Escherichia coli MG1655 (K12) had no impact on intestinal barrier fortification (87). Results presented in other reports suggest that pathogens, such as enterohemorrhagic Escherichia coli (EHEC) O157:H7, enterotoxigenic Escherichia coli (ETEC) K88 and Salmonella typhimurium SL1344, could compromise intestinal barrier integrity. Infection of epithelial cell monolayers with EHEC O157:H7 promoted claudin-1 and ZO-1 redistribution and further down-regulation of ZO-1 expression, while toxins released upon the infection of epithelial cells with ETEC K88 and Salmonella typhimurium SL1344 resulted in disruption of the complexes that maintain adhesion between intestinal epithelial cells (88, 89). Remarkably, the increase in paracellular permeability elicited by these pathogenic bacteria could be ameliorated by certain Lactobacillus species (88, 89). It is worth mentioning that non-pathogenic commensal bacteria could also enhance intestinal barrier permeability, like Escherichia coli C25, which altered claudin-1 localization increasing intestinal permeability in vitro (90).

The influence of microbiota in modulating integrity and functionality of intestinal barrier has been demonstrated in a large bulk of studies showing that gut microbiota dysbiosis could contribute to the alteration of intestinal barrier with notable implications in development and/or progression of diverse pathologies. Cani et al. (91) suggested that microbiota dysbiosis could be the underlying cause of the inflammatory phenotype that characterizes obese and diabetic individuals by disrupting intestinal barrier. They also proposed that an increase of Bifidobacterium species abundance would conduce to higher glucagon-like peptide-2 (GLP-2) production which, among other effects, could led to up-regulation of occludin and ZO-1 expression, decreasing intestinal permeability and culminating in a decrease of inflammation (91). For example, hepatic damage caused by cadmium intake could be exacerbated by microbiota dysbiosis. Low-dose intake of this toxic metal for long periods reduced Akkermansia muciniphila and increased the relative abundance of Acidithiobacillaceae, Gammaproteobacteria, Methylobacterium, and Rhizobiales in mice. The imbalance in microbe proportion affected occludin, claudin-1 and ZO-1 expression, the down-regulation of which increased intestinal permeability, cadmium uptake and subsequent accumulation in the liver (92). Alteration of intestinal microbiota, specifically the decrease in butyrate-producing gram-positive bacteria and the increase in gram-negative bacteria such as Bacteroidetes, would be the cause of intestinal damage produced after skin burns in mice. The authors proposed that decreased butyrate levels would be primarily responsible for the increase of intestinal permeability and inflammation (93, 94).

It has also been reported that disruption of intestinal barrier integrity on the grounds of a severe physiological stress could be the result of microbiota dysbiosis. Specifically, decrease of Actinobacteria, such as Bifidobacterium and Collinsella, and increase of Proteobacteria would cause imbalance of several metabolites, like cysteine, thus increasing intestinal permeability (95). The increase of Proteobacteria has also been associated with the leaky gut phenotype that characterizes patients with acute coronary syndrome (96). Likewise, microbiota dysbiosis has been proposed as a mediator of intestinal permeability changes through dysregulation of immune system of children with beta cell autoimmunity at risk for type 1 diabetes (97). In other diseases such as non-alcoholic steatohepatitis, psychiatric disorders or cancer, it has been suggested that the enhancement of intestinal barrier permeability due to microbiota dysbiosis, could aggravate, and even in some cases be a requirement, for their development (98–102).

With all these supportive data, it appears that microbiota could be a key driving force controlling intestinal permeability, which in turn could modulate bioavailability of nutrients and therefore, their presence in blood circulation for potential biological action. It should be noticed that gut microbiota is not static and immutable but it varies between individuals and even within the same individual throughout life, under normal but also pathological states (103). Age, environment, genetics, diet and physiological status could render account for the aforementioned inter- and intra-individual variability observed in humans (103). Intestinal microbiota, together with genetic variability, are considered leading factors determining bioavailability and bioefficacy of plant bioactive compounds, explaining inter-individual variability concerning their digestion, absorption, distribution, metabolism, and secretion (104). For this reason, we propose that intestinal microbiota could be a major factor determining the amount of xenomiRs absorbed through modulation of intestinal barrier permeability under physiological and pathological conditions. We also suggest that divergence regarding specific configuration of microbiota communities among individuals could entail differences in xenomiR uptake efficiency via mechanisms like modulation of gastrointestinal barrier permeability. Some above evidences of the impact of bacteria on intestinal barrier integrity and functionality can be found in Table 2.

TABLE 2

Table 2. Some evidences of the impact of bacteria on intestinal epithelial barrier functions and integrity.

Involvement of Gut Microbiota in Release of Plant miRNAs From Extracellular Vesicles

Extracellular vesicles have been discovered in both prokaryotic and eukaryotic organisms, including bacteria, archaea, fungi, plants, and mammals. They carry several types of bioactive molecules and thus, they are key factors in intercellular communications (105). In bacteria, extracellular vesicles range from 20 to 400 nm in diameter and they have been involved in bacterial functions such as biofilm formation, competition, antibiotic resistance or horizontal gene transfer (106). Extracellular vesicles of bacterial origin are not only involved in bacteria-bacteria communication, but also in bacteria-host cell communication, being able to elicit phenotypic changes in host cells altering their function with both detrimental and beneficial actions (107–109). Characterization studies of their cargo showed that they can contain several types of molecules, including structural and soluble proteins such as enzymes, secondary metabolites, virulence factors, glycolipids, lipopolysaccharides, bacterial antigens and a wide range of nucleic acids, including DNA and microRNA-like molecules, which have been extensively summarized in other reviews (110–112). Remarkably, gut microbiota can release extracellular vesicles that can influence host physiology, playing part in processes such as digestion (by carrying digestive enzymes), intestinal permeability regulation, metabolism or gut immunity (113–115).

In mammals, extracellular vesicles range in size from 50 to 100 nm in diameter and they modulate system biology as tissue repair, coagulation or embryonic development. Mammalian extracellular vesicles are also involved in disease progression, such as cancer, neurodegenerative and/or metabolic diseases (33, 116–118). The cargo of mammalian extracellular vesicles include lipids (being enriched in lipids such as cholesterol and sphingolipids), cytokines, proteins (in particular plasmatic and cytosolic proteins), nucleic acids (DNA and RNA species, such as miRNAs and mRNAs), amino acids, fatty acids and sugars, and they largely reflect the parental cell content (117, 119, 120). Mammalian extracellular vesicles are classified in microvesicles, exosomes and apoptotic bodies, which differ in their biogenesis and size (121). Contrary to microvesicles and exosomes, apoptotic bodies can contain organelles and chromatin, since they are released from cells undergoing programmed cell death (120). Notably, host extracellular vesicles could also influence gut microbiota, occurring a bidirectional communication mediated by microbiota and host extracellular vesicles (122).

In plants, extracellular vesicles range from 400 to 1,000 nm, depending on the species, and they have similar features (i.e., cargo, morphology and secretion) as mammalian exosomes (110, 123). Plant extracellular vesicles, frequently referred as “exosome-like” nanovesicles, contain lipids, proteins, metabolites and nucleic acids, including smalls RNAs (110, 123, 124). Interestingly, the lipids that constitute the nanovesicle surface confer specificity of uptake by different cell types (125). Plant extracellular vesicles are also known to contain antimicrobial compounds, including defense-signaling lipids and defense-related proteins, and they are involved in functions such as defense against pathogens, immune response, growth and development or symbiosis (124, 126). Plant exosome-like nanovesicles could have an important role in inter-kingdom communication. For example, they could be uptaken by gut microbiota or mammalian cells and their cargo, such as xenomiRs, might have a relevant impact, as it will be further detailed in the following sections (83, 125).

Plant cells can secrete miRNAs to the extracellular medium, as a part of ribonucleoproteins and/or encapsulated in vesicles of different origins (14), which has been reviewed elsewhere (26, 127). It has been observed that a wide range of edible plant can release exosome-like nanovesicles that yield biological effect in mammals. It has also been proposed that plant exosome-like nanovesicles could be an efficient mechanism of transporting bioactive compounds since they provide resistance to degradation, which together with its biocompatibility, led them to even apply as drug delivery system to treat diseases (128–131). The characterization of plant exosome-like nanovesicles has revealed that, among the small RNA cargo, they are enriched in miRNAs, which are selectively loaded in them (128, 132, 133).

Of note, a study carried out by Philip et al. (134) suggested that plant xenomiR bioavailability could be enhanced by processes that promote cell wall disintegration, such as cooking. The authors observed that miRNA levels were higher in cooked beans and brown rice compared to raw controls, and that cooking food promotes the miRNA release into the cooking water. Interestingly, several studies have documented that certain bacteria belonging to Firmicutes and Bacteroides phyla (such as Ruminococcus champanellensis, Bacteroides intestinalis or Bacteroides thetaiotaomicron), which are part of the human gut microbial community, are able to degrade cellulose, hemicellulose and pectins, major components of the cell wall (135–139). In fact, it has been attributed a role for gut microbiota in enhancing bioaccesibility of fiber-encapsulated nutrients, allowing its release through enzymatic activities capable of fermenting plant-cell wall component, which would be crucial for intestinal nutrient absorption (140, 141).

Furthermore, some studies suggested that some gut microbiota bacteria could hydrolyse lipids via lipase enzymes (142). Indeed, specific bacteria from bovine raw milk possess phospholipolytic activity capable of disrupting milk fat globule membranes, whose main constituents are phospholipids, as in cellular membranes and extracellular vesicles (128, 143, 144). Remarkably, it has been proposed that gut microbiota could also utilize lipolytic and phospholipolytic enzymes to digest milk fat, which in turn might led to changes in gut microbiome (145), which should be deeply explored and confirmed in further studies. Indeed, ongoing studies are exploring the biochemical pathway by which gut microbiota could digest milk fat globules through lipolytic and phospholipolytic enzymes activities (146) to further study the relevance of this newly proposed hypothesis.

Although this field of research has not been explored in depth yet, together, the summarized findings have led us to propose the following hypothesis: gut microbiota could contribute to degrade milk fat globule membrane lipids, as well as cellulose, hemicellulose and pectin fibers. In a similar manner, specific gut microbiota composition could be able to hydrolyse envelope lipids of miRNA-containing plant extracellular vesicles and/or cellulose, hemicellulose and pectin fibers (that might have become attached to plant extracellular vesicles during exocytosis and come out across the cell wall), which might enhance the amount of xenomiRs released in the gastrointestinal tract. Therefore, it should be explored if gut microbiota could play a relevant role in determining the bioaccessibility and bioavailability of plant miRNA encapsulated in extracellular vesicles, through degradation of extracellular vesicle envelope components.

Alto, it is worth to underline that plant extracellular vesicles can directly interact with target cells and release their cargo through several mechanisms such as macropinocytosis or endocytosis (28, 147). Thus, one of the issues that pose the above proposed hypothesis on the role of gut microbiota eliciting the release of miRNA from plant extracellular vesicles, is whether (a) it could be a complementary or facilitating mechanism to promote in vivo capture of plant extracellular vesicles, or on the contrary, (b) it could interfere with the suggested selective capture of plant nanovesicles that might depend on the specific lipid membrane composition (125). It would be also worthy to address whether the hypothetical microbiota-dependent plant xenomiR release could entail special relevance in those cases in which plant xenomiRs must be available to exert the documented non-canonical function of binding to cell surface receptor and thus, to modulate cellular signaling pathways (148, 149).

Another issue in which it should be important to dig into consists on determining whether inter-individual differences in gut microbiota composition between healthy subjects or dysbiosis associated to some metabolic diseases like obesity (150, 151) could lead to dissimilarities on the efficiency of the proposed plant xenomiR extracellular vesicles release mechanism. Finally, we hypothesize that gut microbiota could play a major role determining plant xenomiR intestinal absorption rate through the modulation of both miRNA extracellular vesicles release and intestinal barrier permeability, which might partly been explained by the disparity of results regarding the detection of plant xenomiRs in mammals and the eventual veracity of the still controversial plant xenomiR cross-kingdom regulation hypothesis.

Insight on the Impact of Dietary Plant miRNAs on Intestinal Barrier Function and Permeability

Some studies have suggested that most dietary plant xenomiRs would be degraded during digestive processes and the amount that could reach host cells might not be enough to exert cross-kingdom gene expression regulation (71, 82, 152). However, substantial amount of reports has unveiled that plant xenomiRs would be able to withstand harsh conditions of processing, cooking and digestion (22, 23, 134), and thus, could reach a functionally relevant copy number per cell that might surpass a minimum threshold to effectively modulate endogenous host gene expression (153). Within this context, it has been well-documented that factors such as plant miRNA GC content (30), 3'terminal nucleotide 2'-O-metylation of plant miRNAs (13, 29), RNA-binding proteins (154, 155) and especially the packaging into exosome-like nanovesicles (83, 84, 147, 156, 157), are responsible for plant xenomiR stability, greatly endowing them with the capacity to remain unaltered and reach the gastrointestinal tract, to potentially modulate host gene expression.

Another aim of this review is to provide new insights into the potential role of plant xenomiRs in modulating gut barrier function, by interacting with gut microbiota, intestinal epithelial cells and intestinal immune system. The description of the global plant xenomiR effects, once they are absorbed and travel through the bloodstream reaching specific mammalian tissues and organs, goes beyond of the scope of this review and can be found summarized in recent works (17, 127, 158).

xenomiR Influence on Intestinal Permeability Through Modulation of Microbiota Gene Expression

It is well-established that plant small RNAs can be captured by bacteria and fungus plant parasites and down-regulate the expression of genes related to their invasion capacity (21, 159–161). As an example, several studies have found that Arabidopsis thaliana can secrete small RNAs encapsulated in exosome-like extracellular vesicles which have the ability to modulate expression of genes involved in virulence of the fungus Botrytis cinerea and the bacterium Pseudomonas syringae pv. tomato DC3000 (162, 163).

The broad impact of xenomiRs in shaping gut microbiota has also been suggested in some studies. Zhou et al. (164) reported that dietary bovine milk exosomes could modulate gut microbiota composition in mice. They observed that dietary milk exosomes were able to exert a significant impact on the proportion of cecum microbes, stimulating the growth of certain bacteria such as Tenericutes, Firmicutes, and Lachnospiraceae. The authors suggest that dietary milk exosomes-derived miRNAs could be the effectors of the microbiota shaping (164). Similarly, a recent study carried out by Teng et al. (125) establishes a direct causal relationship between plant xenomiRs and alteration of gut microbiota composition and spatial distribution, with physiological consequences on the host. The authors determined that ginger-derived exosome-like nanoparticles could be selectively taken up by Lactobacillus rhamnosus, and the diverse miRNAs carried inside these vesicles could regulate the expression of several bacterial genes improving colitis in mice. For example, gma-miR-396e inhibited the expression of the transcriptional repressor LexA promoting Lactobacillus rhamnosus growth, which started a cascade control through metabolites, having an impact on the growth of other bacteria species like Escherichia coli. Other plant miRNAs like ath-miR-167a could have an influence in the localization of Lactobacillus rhamnosus via regulation of SpaC expression, which is necessary for translocation to the bloodstream, promoting the permanence of the bacteria in the mucosa surface. Furthermore, mdo-miR-7267-3p could down-regulate ycnE expression, increasing indole-3-carboxaldehyde (IA3) production and resulting in reduced gut permeability and enhancement integrity (125).

In view of the fact that certain plant xenomiRs could decrease intestinal permeability through regulation of microbiota gene expression, we suggest that plant xenomiRs could also act in the opposite direction, shaping gut microbiota composition and metabolite production in a way that could promote the increase of gut barrier permeability, which could potentially enhance xenomiR, postbiotics and nutrient absorption.

Role of xenomiRs on Intestinal Permeability Through Modulation of Intestinal Epithelial Cell Functions

Several studies have unveiled that plant exosome-like nanovesicles could target intestinal epithelial cells in mammals and exert biological functions under physiological and pathological conditions. Thus, three independent studies reported that orally delivered fruit-derived exosome-like nanovesicles could be internalized in intestinal stem cells from mice and rats and trigger Wnt/β-catenin signaling pathway, thus enhancing cell proliferation, which contributes to intestinal barrier integrity and homeostasis (28, 83, 156). Interestingly, it has also been shown that some of these nanovesicles, such as grape-exosome-like nanovesicles, could control colitis progression in mice by activating intestinal stem cell Wnt/β-catenin pathway (28). Likewise, results provided by Zhang et al. (84) pointed out that orally administered ginger exosome-like nanoparticles targeted colon intestinal epithelial cells of mice with colitis. There, they promoted cell proliferation, inhibited apoptosis and enhanced the expression of adherent junction proteins like E-cadherin and desmoglein, which, among other factors, led to an improvement of intestinal barrier function and integrity and the attenuation of disease severity. Interestingly, in a colorectal cancer mouse model, ginger exosome-like nanoparticles displayed the opposite effect, inhibiting proliferation and promoting apoptosis of intestinal epithelial cells, which reduced tumorigenesis (84).

In some of the aforementioned studies, the characterization of plant exosome-like nanovesicles cargo revealed that they were enriched for diverse miRNAs, and their bioinformatic analysis revealed that some of them could potentially regulate mammalian gene expression. However, the existence of a direct causal relationship between xenomiRs and the above described extracellular vesicle effects on intestinal epithelial cells was not explored or directly linked (28, 83, 84). Indeed, it could be possible that those extracellular vesicle effects might be dependent on other (complementary) non-xenomiR-related mechanisms.

Interestingly, the direct impact of plant xenomiRs on intestinal epithelial cell gene expression modulation has not been deeply addressed yet. Nevertheless, some studies have proposed that specific xenomiRs could have an impact on intestinal transporter expression or enterocyte proliferation (153, 165, 166), which suggests a potential role for xenomiRs in the modulation of the function of intestinal cells, including molecule absorption or intestinal barrier integrity and functionality. In this context, Fujita et al. (165) reported that Caco-2 cells treated with apple exosome-like nanovesicles displayed changes in mRNA expression of several intestinal transporters including the organic-anion-transporting polypeptide (OATP2B1), whose mRNA and protein expression, along with its activity, decreased, probably by a miRNA-mediated mechanism, which potentially could modulate absorption of orally administered compounds in vivo (165). It has also been reported that synthetic plant miR-167e-5p regulated the expression of Wnt/β-catenin signaling pathway key molecules, such as β-catenin and c-Myc, negatively impacting on enterocyte proliferation in vitro (166). Similar results were also observed for plant miR-156 treatment in vitro and in vivo. Exogenous administration of plant miR-156, as a synthetic form or as a part of the diet, suppressed enterocyte proliferation and affected intestine development in mice. These effects were mediated by specific miRNAs targeting mRNA that drive the expression of Wnt10b, a Wnt/β-catenin pathway component, and by promoting phosphorylation and degradation of β-catenin proteins (153).

It is well-known that Wnt/β-catenin cascade plays a crucial role in controlling epithelial cell proliferation and differentiation and it is essential for the regulation of intestinal homeostasis by contributing to the maintenance of gut barrier integrity and functionality (167, 168). Wnt/β-catenin pathway activation also regulates cell regeneration after epithelial damage by enhancing epithelial cell proliferation (169–171). In this context, a correlation has been described between decreased intestinal cell proliferation and increase of intestinal barrier permeability, which could even aggravate the progression of certain pathologies (172, 173). Wnt/β-catenin pathway could not only influence intestinal barrier permeability by controlling proliferation, but it could also impact on intestinal permeability directly promoting expression of proteins that are part of tight junction, such as claudin-1 and 2 (174–177).

Whether plant xenomiRs could have an impact on intestinal permeability by modulating enterocyte gene expression has not been confirmed yet. Nevertheless, since certain plant xenomiRs could affect the expression of enterocyte transporters and activate Wnt/β-catenin pathway (153, 165, 166), it is plausible that, after being taken up by epithelial cells, xenomiRs could potentially act as regulators of intestinal barrier permeability through their ability to specifically regulate intestinal epithelial mRNAs. Subsequently, this might influence nutrient absorption and even the efficacy of xenomiR absorption as an auto-regulatory loop. It is clear that more evidence is needed to prove the influence of xenomiRs on intestinal permeability through regulation of intestinal cell gene expression and to determine if intestinal permeability could be differently modulated depending on the type of xenomiR.

Relevance of xenomiRs on Intestinal Permeability Through Modulation of Immune System Functions

Growing evidence suggests that plant exosome-like nanovesicles could be taken up by immune system cells and exert immunomodulatory effects. Chen et al. (178) reported that ginger rhizome exosome-like nanovesicles were taken up by macrophages in vitro and repressed inflammasome activation, whose activity has been associated with increased intestinal permeability and progression of diseases like obesity (179, 180). Recently, a study carried out by Cao et al. showed that ginseng-derived nanoparticles led to a decrease of melanoma tumor growth in mice by targeting macrophages and suppressing M2 phenotype switching (181).

Furthermore, several studies have directly confirmed that plant-exosome-like nanoparticles have also biological effects on gut immune system. For example, it has been revealed that plant edible exosome-nanoparticles from several fruits and vegetables, such as ginger, grapefruit or carrot, were selectively taken up by intestinal macrophages and exerted anti-oxidant and anti-inflammatory activities (83, 84, 147). For instance, grapefruit and ginger exosome-nanoparticles were able to reduce inflammation and ameliorated induced colitis in mice (84, 147). Interestingly, many molecules and cytokines whose expression has been shown to be modulated by plant edible nanoparticles in intestinal macrophages, such as IL-6, IL-10, IL-22, heme oxygenase-1 (HO-1), nuclear factor (erythroid-derived 2)-like 2 (Nrf2) TNF-α or IL-1β, are able to regulate intestinal permeability (83, 84, 147, 182–188). Moreover, it has been reported that plant edible nanoparticles could be taken up by other intestinal immune cells, in addition to macrophages, as demonstrated by a study conducted by Deng et al. (189). This study showed that the oral administration of broccoli nanoparticles targeted intestinal dendritic cells and activated adenosine monophosphate-activated protein kinase (AMPK), which induced a tolerogenic dendritic phenotype associated with reduced inflammation and colitis protection (189).

Under these premises, it seems clear that plant exosome-like nanoparticles could enter immune system cells, including gut resident immune cells, and modulate immune function. However, the bioactive molecules responsible for the immunomodulatory effects of plant exosome-like nanoparticles have not been deeply studied yet. Interestingly, some authors suggest that lipids of nanoparticles could be responsible for the observed effects on inflammasome inhibition of macrophages in culture or on the suppression of M2 phenotype of macrophages in melanoma cancer (in the last case, the authors suggest that proteins of nanoparticles may also be involved) (178, 181). Interestingly, characterization of the cargo of edible exosome-like nanoparticles taken up by intestinal macrophages revealed that they are highly enriched in miRNAs, as previously described for intestinal epithelial cells (83, 84, 147). However, the direct implication of xenomiRs on the eventual regulation of immune-modulatory functions has not been explored yet. Indeed, it has not been ruled out that proteins, lipids or other bioactive components present in these nanovesicles, such as naringenin in grape exosome-like nanovesicles or 6-gingerol and 6-shogaol in ginger exosome-like nanoparticles, could be the effectors (83, 84, 147). Another study suggested that sulforaphane was the effector of tolerogenic intestinal dendritic cell induction (189).

Of note, several studies have confirmed that xenomiRs could shape mammalian immune system. It has been recently reported that milk-derived extracellular vesicles, through immune-related miRNAs, could enhance intestinal immune system in mice by stimulating IgA and sIgA production, which play a role in maintaining intestinal barrier integrity and function. The authors also suggest that the modulation of microbiota composition and their metabolites upon the milk-derived exosome treatment could contribute to the shaping of intestinal immune system (190). Notably, there is accumulative evidence showing that milk-derived extracellular vesicles contain plant miRNAs (191, 192), suggesting that eventually, immune system shaping might be attributed to xenomiRs. Indeed, it has been pointed out that plant miRNAs acquired through diet could be captured by human mammary glands, packaged into exosomes and transmitted through milk to infants (193). However, further research is required to determine if plant miRNAs could play part in the immunomodulatory effects assigned so far to milk-derived exosomes (194–197).

Furthermore, Zhang et al. via computational approaches, predicted Arabidopsis thaliana miRNA target genes in humans and their findings revealed that plant xenomiRs could regulate immune system functions, such as leukocyte and lymphocyte activation and inflammation (198). Aquilano et al. provided experimental evidence on the ability of plant miR-159a and miR-156c from nut exosome-like nanovesicles to display anti-inflammatory effects by down-regulating TNF receptor superfamily member 1a (Tnfrsf1a) mRNA expression in macrophages and adipocytes in vitro, which impacted negatively on TNF-α signaling pathway (199). Remarkably, the treatment of diet-induced obese mice with nut exosome-like nanovesicles reduced adipose tissue pro-inflammatory cytokine levels (including TNF-α mRNA) and improved the metabolic profile (199). Several studies have described that intestinal immune system and TNF-α signaling pathway are involved in the increased intestinal permeability observed during obesity by the overexpression of pro-inflammatory cytokines (such as TNF-α) in the intestine, which contribute to the restructuration of the proteins that are part of tight junctions. The dysfunction of intestinal barrier is implicated in the worsening of the disease since it exacerbates endotoxemia and increases circulating pro-inflammatory cytokine levels, enhancing chronic inflammation (187, 200, 201). Since plant miRNAs could suppress TNF-α signaling pathway, it would be interesting to explore if they could modulate intestinal immune system and gut barrier permeability, and if this effect would eventually contribute to the reduction of inflammation in metabolic tissues during obesity development.

Finally, Cavalieri et al. (149) demonstrated that a large range of miRNAs from diverse plant species, through a sequence independent mechanism, could act as Toll-like receptor 3 (TLR3) ligands in dendritic cells, attenuating the innate immune response induced upon an inflammatory stimulus in vitro. The authors also found that plant xenomiRs, via impairment of TLR3 signaling pathway, were able to reduce inflammation and to improve mice autoimmune encephalomyelitis prognosis (149). It should be noted that there is a strong connection between increased intestinal permeability and autoimmune encephalomyelitis onset and progression (202) and that dendritic cells could contribute to intestinal barrier dysfunction in inflammatory diseases (203). These data suggest the potential impact that xenomiR-induced dendritic tolerogenic phenotype induction could have on gut barrier permeability and protection against autoimmune diseases.

It is worthy of note that there are some evidences that plant xenomiRs could shape immune system through gut microbiota modulation, leading to changes in intestinal barrier permeability. In this context, Tent et al. reported that plant mdo-miR-7267-3p repressed ycnE expression in Lactobacillus rhamnosus, upregulating the production of I3A and leading to increased IL-22 production [by activating aryl hydrocarbon receptor (AHR) pathway in lymphocytes], which in turn strengthened gut barrier and improved colitis in mice (125).

Table 3 summarizes most relevant evidences of plant-dietary xenomiRs interaction with mammalian cells. Together, the evidence presented above suggests a potential role for plant xenomiRs in the modulation of cells linked to immune system, including intestinal immunity. It seems that plant xenomiRs might contribute to intestinal barrier integrity and function through mechanisms mediated directly by immune system cells (for example, by means of gene expression regulation or receptor binding and signaling pathway modulation) or acting indirectly on the immune system through gut microbiota. However, further studies are needed to confirm this hypothesis.

TABLE 3

Table 3. Some supporting in vitro and in vivo evidences of the interaction of plant-dietary xenomiRs with mammalian cells.

Conclusions and Future Directions

The current lack of consensus regarding the veracity of the plant-derived xenomiR hypothesis highlights the need to thoroughly identify the factors underlying the high variability of results obtained in the different studies, including optimizing technical methods. One of the factors that might potentially contribute to explain the lack of detection of plant miRNAs in animals by certain studies could be intestinal permeability, since it could play a relevant role in xenomiR absorption. In parallel, there is a strong support for the crucial role of gut microbiota controlling intestinal barrier integrity and function, standing as an important modulator of intestinal permeability. Remarkably, gut microbiota composition varies in an intrinsic manner between healthy individuals (inter-individual variability) and it is well-known that changes in gut microbiota composition and functionality could promote variability in the uptake of plant bioactive compounds through intestinal barrier modulation. Therefore, it would be necessary to explore whether the differences in microbiota composition between healthy subjects could lead to differences in intestinal permeability and whether these normal dissimilarities would be significant enough to endorse variability in xenomiR absorption rate. On the other hand, since gut microbiota dysbiosis could contribute to the onset and progression of a wide range of diseases by affecting intestinal barrier permeability, the link between the alteration of intestinal permeability (as result of gut microbiota specific composition in a pathological context/dysbiosis) and xenomiR bioavailability should also be comprehensively addressed in future researches.

Notably, diet is a key driver in establishing gut microbial communities composition, influencing microbiome diversity and ultimately determining inter-individual microbiome variability (204–207). As part of diet, plant xenomiRs are rising as promising candidates for the modulation of gut microbiota composition, intestinal immune system and intestinal epithelial cells functions, which in turn might affect intestinal barrier permeability and xenomiR absorption efficiency. Nonetheless, further investigation is mandatory to evaluate the potential role of plant xenomiRs on their own absorption and the bioavailability of other bioactive molecules, by shaping microbiota composition, microbe-derived metabolite production, intestinal epithelial cell and immune system function. A schematic representation of the potential interactions and mechanisms of action of plant xenomiRs with mammalian cells within the gastrointestinal tract is depicted in Figure 1.

FIGURE 1

Figure 1. Schematic model of the hypothetical interactions of dietary plant xenomiRs with mammalian cells in the gastrointestinal tract. Gut microbiota could have an impact on intestinal barrier integrity and function, which in turn could modulate gut microbiota through molecules such as miRNAs. There could be also a crosstalk of immune system with both, intestinal barrier and gut microbiota. A certain xenomiR might promote or hinder its absorption depending on its effect on intestinal permeability, which might rely on the crosstalk between gut microbiota, intestinal epithelial cells and immune system. Gut microbiota might also be involved in the release of xenomiRs encapsulated in extracellular vesicles. The increase in intestinal permeability through, for example, altered tight junctions, might enhance xenomiR paracellular transport across the gut barrier, to eventually reach the circulatory system and potentially exert a physiological function in mammal tissues and organs.

It has been proposed that a large variety of microenvironments would exist throughout the gastrointestinal tract and gut microbes would thrive in those niches that best suit their nutritional and environmental requirements, leading to the establishment of diverse microbial communities along the gastrointestinal tract (208). Therefore, diet would be a crucial factor in determining variability of gut microbiota composition between individuals and, within an individual, in establishing different configurations of microbial communities throughout the intestine. In this context, recent studies have suggested that plant miRNAs could contribute to the dietary effect on gut microbiota community's assembly. Thus, Teng et al. proposed that ginger exosome-like nanoparticles small RNAs (and maybe other dietary small RNAs) could be involved in the spatial gut microbiota niche partitioning and in the selection of the bacteria that would be located near the intestinal epithelium (125). This finding provides a new avenue for further studying the following hypotheses:

1) If as a widespread property, plant xenomiRs could create different microenvironments throughout the gastrointestinal tract based on their location specificity and the bacteria they affect (84). This feature would promote specific bacterial selection in the different niches throughout the gastrointestinal tract, and therefore in determining the configuration of diverse microbial communities along de intestine and within different “microbial” layers.

2) If the hypothetical establishment of specific configurations of gut microbe communities and emergence of adaptive gut microbiota changes induced by xenomiRs, could have a direct impact on intestinal barrier integrity and function. Additionally, it should be explored if specific xenomiR-containing eating patterns could affect intestinal integrity and function and thus, determine the bioavailability of bioactive compounds.

Of note, along with proposed modulation of intestinal permeability mediated by the crosstalk between xenomiRs and gut microbiota, immune system and/or intestinal epithelial cells, other factors that would contribute to determine xenomiR bioavailability are the following:

1) Type and amount of xenomiR intake (24).

2) Acute/chronic (or short/long term) specific xenomiR intake (64).

3) XenomiR sequence-dependent absorption (79).

4) XenomiR association with uptake-facilitating molecules (65).

5) Extracellular vesicle transportation stability (83).

6) Gut microbiota hypothetical mediated-variations in the bioaccessibility of encapsulated xenomiRs (through the ability to hydrolyse envelope lipids of miRNA-containing plant extracellular vesicles and/or cellulose, hemicellulose and pectin fibers).

A summary of the most important hypothesis concerning the effect of dietary plant xenomiRs on gut microbiota, intestinal immune system and gastrointestinal barrier presented within this work are summarized in Figure 2.

FIGURE 2

Figure 2. Hypothesis for the effect of dietary xenomiRs on gut microbiota, intestinal immune system and gastrointestinal barrier integrity and functionality.

In conclusion, although it is well-established that gut microbiota plays an important role in determining the integrity and functionality of intestinal barrier, more studies are needed to verify the direct impact of gut microbiota-intestinal permeability modulation on xenomiR absorption efficiency, as well as the role of xenomiRs shaping this process. A better understanding of the interactions of xenomiRs with gut microbiota, immune system and intestinal epithelial cells, in the context of intestinal barrier modulation, could provide new insights on the mechanisms underlying variability of xenomiR intestinal absorption and emerge as new explanatory factors of the discrepancies regarding the hypothesis of xenomiR detection in animals.

Author Contributions

ED-S, SL-C, and FM contributed to the ideas and hypotheses presented in the manuscript. ED-S wrote the paper, which was revised and edited by SL-C, FM, PA, JR-B, and JM. All the authors approved the final version.

Funding

This work was supported by CIBERobn (CB12/03/30002), Mineco (RTI2018-102205-B-I00 project), and a Center for Nutrition Research predoctoral grant awarded to ED-S.

Conflict of Interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

References

1. Bartel DP. Metazoan microRNAs. Cell. (2018) 173:20–51. doi: 10.1016/j.cell.2018.03.006

CrossRef Full Text | Google Scholar

2. Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell. (1993) 75:843–54. doi: 10.1016/0092-8674(93)90529-Y

PubMed Abstract | CrossRef Full Text | Google Scholar

3. Valinezhad Orang A, Safaralizadeh R, Kazemzadeh-Bavili M. Mechanisms of miRNA-mediated gene regulation from common downregulation to mRNA-Specific upregulation. Int J Genomics. (2014) 2014:970607. doi: 10.1155/2014/970607

PubMed Abstract | CrossRef Full Text | Google Scholar

4. Vienberg S, Geiger J, Madsen S, Dalgaard LT. MicroRNAs in metabolism. Acta Physiol. (2017) 219:346–61. doi: 10.1111/apha.12681

CrossRef Full Text | Google Scholar

5. Xiao C, Rajewsky K. MicroRNA control in the immune system: basic principles. Cell. (2009) 136:26–36. doi: 10.1016/j.cell.2008.12.027

PubMed Abstract | CrossRef Full Text | Google Scholar

6. Mens MMJ, Ghanbari M. Cell cycle regulation of stem cells by microRNAs. Stem Cell Rev Rep. (2018) 14:309–22. doi: 10.1007/s12015-018-9808-y

PubMed Abstract | CrossRef Full Text | Google Scholar

7. Gross N, Kropp J, Khatib H. MicroRNA signaling in embryo development. Biology. (2017) 6:34. doi: 10.3390/biology6030034

CrossRef Full Text | Google Scholar

8. Li C, Zhang B. MicroRNAs in control of plant development. J Cell Physiol. (2016) 231:303–13. doi: 10.1002/jcp.25125

CrossRef Full Text | Google Scholar

9. Sunkar R, Li YF, Jagadeeswaran G. Functions of microRNAs in plant stress responses. Trends Plant Sci. (2012) 17:196–203. doi: 10.1016/j.tplants.2012.01.010

PubMed Abstract | CrossRef Full Text | Google Scholar

10. Djami-Tchatchou AT, Sanan-Mishra N, Ntushelo K, Dubery IA. Functional roles of microRNAs in agronomically important plants-potential as targets for crop improvement and protection. Front Plant Sci. (2017) 8:378. doi: 10.3389/fpls.2017.00378

PubMed Abstract | CrossRef Full Text | Google Scholar

11. Szwacka M, Pawełkowicz M, Skarzyńska A, Osipowski P, Wojcieszek M, Przybecki Z, et al. Biological significance, computational analysis, and applications of plant microRNAs. Acta Physiol Plant. (2018) 40:146. doi: 10.1007/s11738-018-2718-4

CrossRef Full Text | Google Scholar

12. Yu B, Yang Z, Li J, Minakhina S, Yang M, Padgett RW, et al. Methylation as a crucial step in plant microRNA biogenesis. Science. (2005) 307:932–5. doi: 10.1126/science.1107130

PubMed Abstract | CrossRef Full Text | Google Scholar

13. Li J, Yang Z, Yu B, Liu J, Chen X. Methylation protects miRNAs and siRNAs from a 3'-end uridylation activity in Arabidopsis. Curr Biol. (2005) 15:1501–7. doi: 10.1016/j.cub.2005.07.029

PubMed Abstract | CrossRef Full Text | Google Scholar

14. Kehr J, Kragler F. Long distance RNA movement. New Phytol. (2018) 218:29–40. doi: 10.1111/nph.15025

CrossRef Full Text | Google Scholar

15. Reagan BC, Ganusova EE, Fernandez JC, McCray TN, Burch-Smith TM. RNA on the move: the plasmodesmata perspective. Plant Sci. (2018) 275:1–10. doi: 10.1016/j.plantsci.2018.07.001

PubMed Abstract | CrossRef Full Text | Google Scholar

16. Pagliarani C, Gambino G. Small RNA mobility: spread of RNA silencing effectors and its effect on developmental processes and stress adaptation in plants. Int J Mol Sci. (2019) 20:4306. doi: 10.3390/ijms20174306

PubMed Abstract | CrossRef Full Text | Google Scholar

17. Li Z, Xu R, Li N. MicroRNAs from plants to animals, do they define a new messenger for communication? Nutr Metab. (2018) 15:68. doi: 10.1186/s12986-018-0305-8

PubMed Abstract | CrossRef Full Text | Google Scholar

18. Zeng J, Gupta VK, Jiang Y, Yang B, Gong L, Zhu H. Cross-kingdom small RNAs among animals, plants and microbes. Cells. (2019) 8:371. doi: 10.3390/cells8040371

PubMed Abstract | CrossRef Full Text | Google Scholar

19. Wang W, Liu D, Zhang X, Chen D, Cheng Y, Shen F. Plant microRNAs in cross-kingdom regulation of gene expression. Int J Mol Sci. (2018) 19:2007. doi: 10.3390/ijms19072007

PubMed Abstract | CrossRef Full Text | Google Scholar

20. Weiberg A, Wang M, Bellinger M, Jin H. Small RNAs: a new paradigm in plant-microbe interactions. Annu Rev Phytopathol. (2014) 52:495–516. doi: 10.1146/annurev-phyto-102313-045933

PubMed Abstract | CrossRef Full Text | Google Scholar

21. Zhao JH, Guo HS. Trans-kingdom RNA interactions drive the evolutionary arms race between hosts and pathogens. Curr Opin Genet Dev. (2019) 58–59:62–9. doi: 10.1016/j.gde.2019.07.019

PubMed Abstract | CrossRef Full Text | Google Scholar

22. Liang G, Zhu Y, Sun B, Shao Y, Jing A, Wang J, et al. Assessing the survival of exogenous plant microRNA in mice. Food Sci Nutr. (2014) 2:380–8. doi: 10.1002/fsn3.113

PubMed Abstract | CrossRef Full Text | Google Scholar

23. Luo Y, Wang P, Wang X, Wang Y, Mu Z, Li Q, et al. Detection of dietetically absorbed maize-derived microRNAs in pigs. Sci Rep. (2017) 7:645. doi: 10.1038/s41598-017-00488-y

PubMed Abstract | CrossRef Full Text | Google Scholar

24. Liang H, Zhang S, Fu Z, Wang Y, Wang N, Liu Y, et al. Effective detection and quantification of dietetically absorbed plant microRNAs in human plasma. J Nutr Biochem. (2015) 26:505–12. doi: 10.1016/j.jnutbio.2014.12.002

PubMed Abstract | CrossRef Full Text | Google Scholar

25. Witwer KW, Hirschi KD. Transfer and functional consequences of dietary microRNAs in vertebrates: concepts in search of corroboration: negative results challenge the hypothesis that dietary xenomiRs cross the gut and regulate genes in ingesting vertebrates, but important questions persist. Bioessays. (2014) 36:394–406. doi: 10.1002/bies.201300150

PubMed Abstract | CrossRef Full Text | Google Scholar

26. Xie W, Weng A, Melzig MF. MicroRNAs as new bioactive components in medicinal plants. Planta Med. (2016) 82:1153–62. doi: 10.1055/s-0042-108450

PubMed Abstract | CrossRef Full Text | Google Scholar

27. Conner SD, Schmid SL. Regulated portals of entry into the cell. Nature. (2003) 422:37–44. doi: 10.1038/nature01451

CrossRef Full Text | Google Scholar

28. Ju S, Mu J, Dokland T, Zhuang X, Wang Q, Jiang H, et al. Grape exosome-like nanoparticles induce intestinal stem cells and protect mice from DSS-induced colitis. Mol Ther. (2013) 21:1345–57. doi: 10.1038/mt.2013.64

PubMed Abstract | CrossRef Full Text | Google Scholar

29. Zhang L, Hou D, Chen X, Li D, Zhu L, Zhang Y, et al. Exogenous plant MIR168a specifically targets mammalian LDLRAP1: evidence of cross-kingdom regulation by microRNA. Cell Res. (2012) 22:107–26. doi: 10.1038/cr.2011.158

PubMed Abstract | CrossRef Full Text | Google Scholar

30. Zhou Z, Li X, Liu J, Dong L, Chen Q, Liu J, et al. Honeysuckle-encoded atypical microRNA2911 directly targets influenza A viruses. Cell Res. (2015) 25:39–49. doi: 10.1038/cr.2014.130

PubMed Abstract | CrossRef Full Text | Google Scholar

31. Yang J, Hotz T, Broadnax L, Yarmarkovich M, Elbaz-Younes I, Hirschi KD. Anomalous uptake and circulatory characteristics of the plant-based small RNA MIR2911. Sci Rep. (2016) 6:26834. doi: 10.1038/srep26834

PubMed Abstract | CrossRef Full Text | Google Scholar

32. Diallo I, Provost P. RNA-sequencing analyses of small bacterial RNAs and their emergence as virulence factors in host-pathogen interactions. Int J Mol Sci. (2020) 21:1627. doi: 10.3390/ijms21051627

PubMed Abstract | CrossRef Full Text | Google Scholar

33. Gottesman S, Storz G. Bacterial small RNA regulators: versatile roles and rapidly evolving variations. Cold Spring Harb Perspect Biol. (2011) 3:a003798. doi: 10.1101/cshperspect.a003798

PubMed Abstract | CrossRef Full Text | Google Scholar

34. Layton E, Fairhurst A-M, Griffiths-Jones S, Grencis RK, Roberts IS. Regulatory RNAs: a universal language for inter-domain communication. Int J Mol Sci. (2020) 21:8919. doi: 10.3390/ijms21238919

PubMed Abstract | CrossRef Full Text | Google Scholar

35. Bloch S, Wegrzyn A, Wegrzyn G, Nejman-Faleńczyk B. Small and smaller—sRNAs and microRNAs in the regulation of toxin gene expression in prokaryotic cells: a mini-review. Toxins. (2017) 9:181. doi: 10.3390/toxins9060181

PubMed Abstract | CrossRef Full Text | Google Scholar

36. Choi J-W, Um J-H, Cho J-H, Lee H-J. Tiny RNAs and their voyage via extracellular vesicles: secretion of bacterial small RNA and eukaryotic microRNA. Exp Biol Med. (2017) 242:1475–81. doi: 10.1177/1535370217723166

PubMed Abstract | CrossRef Full Text | Google Scholar

37. Lee H-J, Hong S-H. Analysis of microRNA-size, small RNAs in Streptococcus mutans by deep sequencing. FEMS Microbiol Lett. (2012) 326:131–6. doi: 10.1111/j.1574-6968.2011.02441.x

PubMed Abstract | CrossRef Full Text | Google Scholar

38. Kang S-M, Choi J-W, Lee Y, Hong S-H, Lee H-J. Identification of microRNA-size, small RNAs in Escherichia coli. Curr Microbiol. (2013) 67:609–13. doi: 10.1007/s00284-013-0411-9

PubMed Abstract | CrossRef Full Text | Google Scholar

39. Choi J-W, Kim S-C, Hong S-H, Lee H-J. Secretable Small RNAs via Outer Membrane Vesicles in Periodontal Pathogens. J Dent Res. (2017) 96:458–66. doi: 10.1177/0022034516685071

PubMed Abstract | CrossRef Full Text | Google Scholar

40. Gu H, Zhao C, Zhang T, Liang H, Wang X-M, Pan Y, et al. Salmonella produce microRNA-like RNA fragment Sal-1 in the infected cells to facilitate intracellular survival. Sci Rep. (2017) 7:2392. doi: 10.1038/s41598-017-02669-1

PubMed Abstract | CrossRef Full Text

41. Turnbaugh PJ, Ridaura VK, Faith JJ, Rey FE, Knight R, Gordon JI. The effect of diet on the human gut microbiome: a metagenomic analysis in humanized gnotobiotic mice. Sci Transl Med. (2009) 1:6ra14. doi: 10.1126/scitranslmed.3000322

PubMed Abstract | CrossRef Full Text | Google Scholar

42. David LA, Maurice CF, Carmody RN, Gootenberg DB, Button JE, Wolfe BE, et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature. (2014) 505:559–63. doi: 10.1038/nature12820

PubMed Abstract | CrossRef Full Text | Google Scholar

43. Flint HJ. The impact of nutrition on the human microbiome. Nutr Rev. (2012) 70 (Suppl. 1):S10–3. doi: 10.1111/j.1753-4887.2012.00499.x

PubMed Abstract | CrossRef Full Text | Google Scholar

44. Tremaroli V, Backhed F. Functional interactions between the gut microbiota and host metabolism. Nature. (2012) 489:242–9. doi: 10.1038/nature11552

PubMed Abstract | CrossRef Full Text | Google Scholar

45. Yadav M, Verma MK, Chauhan NS. A review of metabolic potential of human gut microbiome in human nutrition. Arch Microbiol. (2018) 200:203–17. doi: 10.1007/s00203-017-1459-x

PubMed Abstract | CrossRef Full Text | Google Scholar

46. Zheng D, Liwinski T, Elinav E. Interaction between microbiota and immunity in health and disease. Cell Res. (2020) 30:492–506. doi: 10.1038/s41422-020-0332-7

PubMed Abstract | CrossRef Full Text | Google Scholar

47. Pickard JM, Zeng MY, Caruso R, Nunez G. Gut microbiota: role in pathogen colonization, immune responses, and inflammatory disease. Immunol Rev. (2017) 279:70–89. doi: 10.1111/imr.12567

PubMed Abstract | CrossRef Full Text | Google Scholar

48. Sharma R, Young C, Neu J. Molecular modulation of intestinal epithelial barrier: contribution of microbiota. J Biomed Biotechnol. (2010) 2010:305879. doi: 10.1155/2010/305879

PubMed Abstract | CrossRef Full Text | Google Scholar

49. Beaumont M, Paës C, Mussard E, Knudsen C, Cauquil L, Aymard P, et al. Gut microbiota derived metabolites contribute to intestinal barrier maturation at the suckling-to-weaning transition. Gut Microbes. (2020) 11:1268–86. doi: 10.1080/19490976.2020.1747335

PubMed Abstract | CrossRef Full Text | Google Scholar

50. Shimada Y, Kinoshita M, Harada K, Mizutani M, Masahata K, Kayama H, et al. Commensal bacteria-dependent indole production enhances epithelial barrier function in the colon. PLoS ONE. (2013) 8:e80604. doi: 10.1371/journal.pone.0080604

PubMed Abstract | CrossRef Full Text | Google Scholar

51. Alam A, Neish A. Role of gut microbiota in intestinal wound healing and barrier function. Tissue Barriers. (2018) 6:1539595. doi: 10.1080/21688370.2018.1539595

PubMed Abstract | CrossRef Full Text | Google Scholar

52. Horne R, St Pierre J, Odeh S, Surette M, Foster JA. Microbe and host interaction in gastrointestinal homeostasis. Psychopharmacology. (2019) 236:1623–40. doi: 10.1007/s00213-019-05218-y

PubMed Abstract | CrossRef Full Text | Google Scholar

53. Liu S, da Cunha AP, Rezende RM, Cialic R, Wei Z, Bry L, et al. The host shapes the gut microbiota via fecal microRNA. Cell Host Microbe. (2016) 19:32–43. doi: 10.1016/j.chom.2015.12.005

PubMed Abstract | CrossRef Full Text | Google Scholar

54. Nakata K, Sugi Y, Narabayashi H, Kobayakawa T, Nakanishi Y, Tsuda M, et al. Commensal microbiota-induced microRNA modulates intestinal epithelial permeability through the small GTPase ARF4. J Biol Chem. (2017) 292:15426–33. doi: 10.1074/jbc.M117.788596

PubMed Abstract | CrossRef Full Text | Google Scholar

55. Dalmasso G, Nguyen HT, Yan Y, Laroui H, Charania MA, Ayyadurai S, et al. Microbiota modulate host gene expression via microRNAs. PLoS ONE. (2011) 6:e19293. doi: 10.1371/journal.pone.0019293

PubMed Abstract | CrossRef Full Text | Google Scholar

56. Peck BC, Mah AT, Pitman WA, Ding S, Lund PK, Sethupathy P. Functional transcriptomics in diverse intestinal epithelial cell types reveals robust microRNA sensitivity in intestinal stem cells to microbial status. J Biol Chem. (2017) 292:2586–600. doi: 10.1074/jbc.M116.770099

PubMed Abstract | CrossRef Full Text | Google Scholar

57. Pita T, Feliciano JR, Leitão JH. Extracellular RNAs in bacterial infections: from emerging key players on host-pathogen interactions to exploitable biomarkers and therapeutic targets. Int J Mol Sci. (2020) 21:9634. doi: 10.3390/ijms21249634

PubMed Abstract | CrossRef Full Text | Google Scholar

58. Shmaryahu A, Carrasco M, Valenzuela PDT. Prediction of bacterial microRNAs and possible targets in human cell transcriptome. J Microbiol. (2014) 52:482–9. doi: 10.1007/s12275-014-3658-3

PubMed Abstract | CrossRef Full Text | Google Scholar

59. Sarshar M, Scribano D, Ambrosi C, Palamara AT, Masotti A. Fecal microRNAs as innovative biomarkers of intestinal diseases and effective players in host-microbiome interactions. Cancers. (2020) 12:2174. doi: 10.3390/cancers12082174

PubMed Abstract | CrossRef Full Text | Google Scholar

60. Ghosal A. Secreted bacterial RNA: an unexplored avenue. FEMS Microbiol Lett. (2018) 365. doi: 10.1093/femsle/fny036

PubMed Abstract | CrossRef Full Text | Google Scholar

61. Yang J, Farmer LM, Agyekum AA, Hirschi KD. Detection of dietary plant-based small RNAs in animals. Cell Res. (2015) 25:517–20. doi: 10.1038/cr.2015.26

PubMed Abstract | CrossRef Full Text | Google Scholar

62. Yang J, Farmer LM, Agyekum AA, Elbaz-Younes I, Hirschi KD. Detection of an Abundant Plant-Based Small RNA in Healthy Consumers. PLoS ONE. (2015) 10:e0137516. doi: 10.1371/journal.pone.0137516

PubMed Abstract | CrossRef Full Text | Google Scholar

63. Mlotshwa S, Pruss GJ, MacArthur JL, Endres MW, Davis C, Hofseth LJ, et al. A novel chemopreventive strategy based on therapeutic microRNAs produced in plants. Cell Res. (2015) 25:521–4. doi: 10.1038/cr.2015.25

PubMed Abstract | CrossRef Full Text | Google Scholar

64. Chin AR, Fong MY, Somlo G, Wu J, Swiderski P, Wu X, et al. Cross-kingdom inhibition of breast cancer growth by plant miR159. Cell Res. (2016) 26:217–28. doi: 10.1038/cr.2016.13

PubMed Abstract | CrossRef Full Text | Google Scholar

65. Du J, Liang Z, Xu J, Zhao Y, Li X, Zhang Y, et al. Plant-derived phosphocholine facilitates cellular uptake of anti-pulmonary fibrotic HJT-sRNA-m7. Sci China Life Sci. (2019) 62:309–20. doi: 10.1007/s11427-017-9026-7

PubMed Abstract | CrossRef Full Text | Google Scholar

66. Svezia B, Cabiati M, Matteucci M, Passino C, Pe ME, Lionetti V, et al. Tuscany Sangiovese grape juice imparts cardioprotection by regulating gene expression of cardioprotective C-type natriuretic peptide. Eur J Nutr. (2019) 59:2953–68. doi: 10.1007/s00394-019-02134-x

PubMed Abstract | CrossRef Full Text | Google Scholar

67. Zhang Y, Wiggins BE, Lawrence C, Petrick J, Ivashuta S, Heck G. Analysis of plant-derived miRNAs in animal small RNA datasets. BMC Genomics. (2012) 13:381. doi: 10.1186/1471-2164-13-381

PubMed Abstract | CrossRef Full Text | Google Scholar

68. Dickinson B, Zhang Y, Petrick JS, Heck G, Ivashuta S, Marshall WS. Lack of detectable oral bioavailability of plant microRNAs after feeding in mice. Nat Biotechnol. (2013) 31:965–7. doi: 10.1038/nbt.2737

PubMed Abstract | CrossRef Full Text | Google Scholar

69. Snow JW, Hale AE, Isaacs SK, Baggish AL, Chan SY. Ineffective delivery of diet-derived microRNAs to recipient animal organisms. RNA Biol. (2013) 10:1107–16. doi: 10.4161/rna.24909

PubMed Abstract | CrossRef Full Text | Google Scholar

70. Witwer KW, McAlexander MA, Queen SE, Adams RJ. Real-time quantitative PCR and droplet digital PCR for plant miRNAs in mammalian blood provide little evidence for general uptake of dietary miRNAs: limited evidence for general uptake of dietary plant xenomiRs. RNA Biol. (2013) 10:1080–6. doi: 10.4161/rna.25246

PubMed Abstract | CrossRef Full Text | Google Scholar

71. Huang H, Davis CD, Wang TTY. Extensive degradation and low bioavailability of orally consumed corn miRNAs in mice. Nutrients. (2018) 10:215. doi: 10.3390/nu10020215

PubMed Abstract | CrossRef Full Text | Google Scholar

72. Mico V, Martin R, Lasuncion MA, Ordovas JM, Daimiel L. Unsuccessful detection of plant microRNAs in beer, extra virgin olive oil and human plasma after an acute ingestion of extra virgin olive oil. Plant Foods Hum Nutr. (2016) 71:102–8. doi: 10.1007/s11130-016-0534-9

PubMed Abstract | CrossRef Full Text | Google Scholar

73. Pastrello C, Tsay M, McQuaid R, Abovsky M, Pasini E, Shirdel E, et al. Circulating plant miRNAs can regulate human gene expression in vitro. Sci Rep. (2016) 6:32773. doi: 10.1038/srep32773

PubMed Abstract | CrossRef Full Text | Google Scholar

74. Pastrello C, Tsay M, McQuaid R, Abovsky M, Pasini E, Shirdel E, et al. Retraction: circulating plant miRNAs can regulate human gene expression in vitro. Sci Rep. (2017) 7:46826. doi: 10.1038/srep46826

PubMed Abstract | CrossRef Full Text | Google Scholar

75. Tosar JP, Rovira C, Naya H, Cayota A. Mining of public sequencing databases supports a non-dietary origin for putative foreign miRNAs: underestimated effects of contamination in NGS. RNA. (2014) 20:754–7. doi: 10.1261/rna.044263.114

PubMed Abstract | CrossRef Full Text | Google Scholar

76. Kang W, Bang-Berthelsen CH, Holm A, Houben AJ, Muller AH, Thymann T, et al. Survey of 800+ data sets from human tissue and body fluid reveals xenomiRs are likely artifacts. RNA. (2017) 23:433–45. doi: 10.1261/rna.059725.116

PubMed Abstract | CrossRef Full Text | Google Scholar

77. Heintz-Buschart A, Yusuf D, Kaysen A, Etheridge A, Fritz JV, May P, et al. Small RNA profiling of low biomass samples: identification and removal of contaminants. BMC Biol. (2018) 16:52. doi: 10.1186/s12915-018-0522-7

PubMed Abstract | CrossRef Full Text | Google Scholar

78. Zhao Q, Liu Y, Zhang N, Hu M, Zhang H, Joshi T, et al. Evidence for plant-derived xenomiRs based on a large-scale analysis of public small RNA sequencing data from human samples. PLoS ONE. (2018) 13:e0187519. doi: 10.1371/journal.pone.0187519

PubMed Abstract | CrossRef Full Text | Google Scholar

79. Zhao Q, Mao Q, Zhao Z, Dou T, Wang Z, Cui X, et al. Prediction of plant-derived xenomiRs from plant miRNA sequences using random forest and one-dimensional convolutional neural network models. BMC Genomics. (2018) 19:839. doi: 10.1186/s12864-018-5227-3

PubMed Abstract | CrossRef Full Text | Google Scholar

80. Raoof AA, Chiu P, Ramtoola Z, Cumming IK, Teng C, Weinbach SP, et al. Oral bioavailability and multiple dose tolerability of an antisense oligonucleotide tablet formulated with sodium caprate. J Pharm Sci. (2004) 93:1431–9. doi: 10.1002/jps.20051

PubMed Abstract | CrossRef Full Text | Google Scholar

81. Radloff J, Cornelius V, Markov AG, Amasheh S. Caprate modulates intestinal barrier function in porcine peyer's patch follicle-associated epithelium. Int J Mol Sci. (2019) 20:1418. doi: 10.3390/ijms20061418

PubMed Abstract | CrossRef Full Text | Google Scholar

82. Yang J, Elbaz-Younes I, Primo C, Murungi D, Hirschi KD. Intestinal permeability, digestive stability and oral bioavailability of dietary small RNAs. Sci Rep. (2018) 8:10253. doi: 10.1038/s41598-018-28207-1

PubMed Abstract | CrossRef Full Text | Google Scholar

83. Mu J, Zhuang X, Wang Q, Jiang H, Deng ZB, Wang B, et al. Interspecies communication between plant and mouse gut host cells through edible plant derived exosome-like nanoparticles. Mol Nutr Food Res. (2014) 58:1561–73. doi: 10.1002/mnfr.201300729

PubMed Abstract | CrossRef Full Text | Google Scholar

84. Zhang M, Viennois E, Prasad M, Zhang Y, Wang L, Zhang Z, et al. Edible ginger-derived nanoparticles: a novel therapeutic approach for the prevention and treatment of inflammatory bowel disease and colitis-associated cancer. Biomaterials. (2016) 101:321–40. doi: 10.1016/j.biomaterials.2016.06.018

PubMed Abstract | CrossRef Full Text | Google Scholar

85. Hayes CL, Dong J, Galipeau HJ, Jury J, McCarville J, Huang X, et al. Commensal microbiota induces colonic barrier structure and functions that contribute to homeostasis. Sci Rep. (2018) 8:14184. doi: 10.1038/s41598-018-32366-6

PubMed Abstract | CrossRef Full Text | Google Scholar

86. Hooper LV, Wong MH, Thelin A, Hansson L, Falk PG, Gordon JI. Molecular analysis of commensal host-microbial relationships in the intestine. Science. (2001) 291:881–4. doi: 10.1126/science.291.5505.881

PubMed Abstract | CrossRef Full Text | Google Scholar

87. Ukena SN, Singh A, Dringenberg U, Engelhardt R, Seidler U, Hansen W, et al. Probiotic Escherichia coli Nissle 1917 inhibits leaky gut by enhancing mucosal integrity. PLoS ONE. (2007) 2:e1308. doi: 10.1371/journal.pone.0001308

PubMed Abstract | CrossRef Full Text | Google Scholar

88. Johnson-Henry KC, Donato KA, Shen-Tu G, Gordanpour M, Sherman PM. Lactobacillus rhamnosus strain GG prevents enterohemorrhagic Escherichia coli O157:H7-induced changes in epithelial barrier function. Infect Immun. (2008) 76:1340–8. doi: 10.1128/IAI.00778-07

PubMed Abstract | CrossRef Full Text | Google Scholar

89. Yu Q, Yuan L, Deng J, Yang Q. Lactobacillus protects the integrity of intestinal epithelial barrier damaged by pathogenic bacteria. Front Cell Infect Microbiol. (2015) 5:26. doi: 10.3389/fcimb.2015.00026

PubMed Abstract | CrossRef Full Text | Google Scholar

90. Zareie M, Riff J, Donato K, McKay DM, Perdue MH, Soderholm JD, et al. Novel effects of the prototype translocating Escherichia coli, strain C25 on intestinal epithelial structure and barrier function. Cell Microbiol. (2005) 7:1782–97. doi: 10.1111/j.1462-5822.2005.00595.x

PubMed Abstract | CrossRef Full Text | Google Scholar

91. Cani PD, Possemiers S, Van de Wiele T, Guiot Y, Everard A, Rottier O, et al. Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut. (2009) 58:1091–103. doi: 10.1136/gut.2008.165886

PubMed Abstract | CrossRef Full Text | Google Scholar

92. Liu Y, Li Y, Xia Y, Liu K, Ren L, Ji Y. The dysbiosis of gut microbiota caused by low-dose cadmium aggravate the injury of mice liver through increasing intestinal permeability. Microorganisms. (2020) 8:211. doi: 10.3390/microorganisms8020211

PubMed Abstract | CrossRef Full Text | Google Scholar

93. Zhang D, Zhu C, Fang Z, Zhang H, Yang J, Tao K, et al. Remodeling gut microbiota by Clostridium butyricum (C. butyricum) attenuates intestinal injury in burned mice. Burns. (2020) 46:1373–80. doi: 10.1016/j.burns.2020.01.007

PubMed Abstract | CrossRef Full Text | Google Scholar

94. Kuethe JW, Armocida SM, Midura EF, Rice TC, Hildeman DA, Healy DP, et al. Fecal microbiota transplant restores mucosal integrity in a murine model of burn injury. Shock. (2016) 45:647–52. doi: 10.1097/SHK.0000000000000551

PubMed Abstract | CrossRef Full Text | Google Scholar

95. Karl JP, Margolis LM, Madslien EH, Murphy NE, Castellani JW, Gundersen Y, et al. Changes in intestinal microbiota composition and metabolism coincide with increased intestinal permeability in young adults under prolonged physiological stress. Am J Physiol Gastrointest Liver Physiol. (2017) 312:G559–71. doi: 10.1152/ajpgi.00066.2017

PubMed Abstract | CrossRef Full Text | Google Scholar

96. Alhmoud T, Kumar A, Lo C-C, Al-Sadi R, Clegg S, Alomari I, et al. Investigating intestinal permeability and gut microbiota roles in acute coronary syndrome patients. Hum Microb J. (2019) 13:100059. doi: 10.1016/j.humic.2019.100059

CrossRef Full Text | Google Scholar

97. Maffeis C, Martina A, Corradi M, Quarella S, Nori N, Torriani S, et al. Association between intestinal permeability and faecal microbiota composition in Italian children with beta cell autoimmunity at risk for type 1 diabetes. Diabetes Metab Res Rev. (2016) 32:700–9. doi: 10.1002/dmrr.2790

PubMed Abstract | CrossRef Full Text | Google Scholar

98. Mouries J, Brescia P, Silvestri A, Spadoni I, Sorribas M, Wiest R, et al. Microbiota-driven gut vascular barrier disruption is a prerequisite for non-alcoholic steatohepatitis development. J Hepatol. (2019) 71:1216–28. doi: 10.1016/j.jhep.2019.08.005

PubMed Abstract | CrossRef Full Text | Google Scholar

99. Neu J, Reverte CM, Mackey AD, Liboni K, Tuhacek-Tenace LM, Hatch M, et al. Changes in intestinal morphology and permeability in the biobreeding rat before the onset of type 1 diabetes. J Pediatr Gastroenterol Nutr. (2005) 40:589–95. doi: 10.1097/01.MPG.0000159636.19346.C1

PubMed Abstract | CrossRef Full Text | Google Scholar

100. Zheng P, Zeng B, Liu M, Chen J, Pan J, Han Y, et al. The gut microbiome from patients with schizophrenia modulates the glutamate-glutamine-GABA cycle and schizophrenia-relevant behaviors in mice. Sci Adv. (2019) 5:eaau8317. doi: 10.1126/sciadv.aau8317

PubMed Abstract | CrossRef Full Text | Google Scholar

101. Wu W, Kong Q, Tian P, Zhai Q, Wang G, Liu X, et al. Targeting gut microbiota dysbiosis: potential intervention strategies for neurological disorders. Engineering. (2020) 6:415–23. doi: 10.1016/j.eng.2019.07.026

CrossRef Full Text | Google Scholar

102. Sobhani I, Bergsten E, Couffin S, Amiot A, Nebbad B, Barau C, et al. Colorectal cancer-associated microbiota contributes to oncogenic epigenetic signatures. Proc Natl Acad Sci USA. (2019) 116:24285–95. doi: 10.1073/pnas.1912129116

PubMed Abstract | CrossRef Full Text | Google Scholar

103. Lozupone CA, Stombaugh JI, Gordon JI, Jansson JK, Knight R. Diversity, stability and resilience of the human gut microbiota. Nature. (2012) 489:220–30. doi: 10.1038/nature11550

PubMed Abstract | CrossRef Full Text | Google Scholar

104. Landberg R, Manach C, Kerckhof FM, Minihane AM, Saleh RNM, De Roos B, et al. Future prospects for dissecting inter-individual variability in the absorption, distribution and elimination of plant bioactives of relevance for cardiometabolic endpoints. Eur J Nutr. (2019) 58:21–36. doi: 10.1007/s00394-019-02095-1

PubMed Abstract | CrossRef Full Text | Google Scholar

105. Kim KW. Visualization of extracellular vesicles of prokaryotes and eukaryotic microbes. Appl Microsc. (2018) 48:96–101. doi: 10.9729/AM.2018.48.4.96

CrossRef Full Text | Google Scholar

106. Kulp A, Kuehn MJ. Biological functions and biogenesis of secreted bacterial outer membrane vesicles. Annu Rev Microbiol. (2010) 64:163–84. doi: 10.1146/annurev.micro.091208.073413

PubMed Abstract | CrossRef Full Text | Google Scholar

107. Chronopoulos A, Kalluri R. Emerging role of bacterial extracellular vesicles in cancer. Oncogene. (2020) 39:6951–60. doi: 10.1038/s41388-020-01509-3

PubMed Abstract | CrossRef Full Text | Google Scholar

108. Kim Y-Y, Joh JS, Lee JY. Importance of microbial extracellular vesicle in the pathogenesis of asthma and chronic obstructive pulmonary disease and its diagnostic potential. Asia Pac Allergy. (2020) 10:e25. doi: 10.5415/apallergy.2020.10.e25

PubMed Abstract | CrossRef Full Text | Google Scholar

109. Kang C, Ban M, Choi E-J, Moon H-G, Jeon J-S, Kim D-K, et al. Extracellular vesicles derived from gut microbiota, especially akkermansia muciniphila, protect the progression of dextran sulfate sodium-induced colitis. PLoS ONE. (2013) 8:e76520. doi: 10.1371/journal.pone.0076520

PubMed Abstract | CrossRef Full Text | Google Scholar

110. Woith E, Fuhrmann G, Melzig MF. Extracellular vesicles-connecting kingdoms. Int J Mol Sci. (2019) 20:5695. doi: 10.3390/ijms20225695

CrossRef Full Text | Google Scholar

111. Dauros-Singorenko P, Blenkiron C, Phillips A, Swift S. The functional RNA cargo of bacterial membrane vesicles. FEMS Microbiol Lett. (2018) 365. doi: 10.1093/femsle/fny023

PubMed Abstract | CrossRef Full Text | Google Scholar

112. Wang YF, Fu J. Secretory and circulating bacterial small RNAs: a mini-review of the literature. ExRNA. (2019) 1:14. doi: 10.1186/s41544-019-0015-z

CrossRef Full Text | Google Scholar

113. Chelakkot C, Choi Y, Kim D-K, Park HT, Ghim J, Kwon Y, et al. Akkermansia muciniphila-derived extracellular vesicles influence gut permeability through the regulation of tight junctions. Exp Mol Med. (2018) 50:e450. doi: 10.1038/emm.2017.282

PubMed Abstract | CrossRef Full Text | Google Scholar

114. Ahmadi Badi S, Moshiri A, Fateh A, Rahimi Jamnani F, Sarshar M, Vaziri F, et al. Microbiota-derived extracellular vesicles as new systemic regulators. Front Microbiol. (2017) 8:1610. doi: 10.3389/fmicb.2017.01610

PubMed Abstract | CrossRef Full Text | Google Scholar

115. Choi Y, Kwon Y, Kim D-K, Jeon J, Jang SC, Wang T, et al. Gut microbe-derived extracellular vesicles induce insulin resistance, thereby impairing glucose metabolism in skeletal muscle. Sci Rep. (2015) 5:15878. doi: 10.1038/srep15878

PubMed Abstract | CrossRef Full Text | Google Scholar

116. Kalluri R, LeBleu VS. The biology, function, and biomedical applications of exosomes. Science. (2020) 367:eaau6977. doi: 10.1126/science.aau6977

PubMed Abstract | CrossRef Full Text | Google Scholar

117. Yáñez-Mó M, Siljander PR-M, Andreu Z, Bedina Zavec A, Borràs FE, Buzas EI, et al. Biological properties of extracellular vesicles and their physiological functions. J Extracell Vesicles. (2015) 4:27066. doi: 10.3402/jev.v4.27066

PubMed Abstract | CrossRef Full Text | Google Scholar

118. Akbar N, Azzimato V, Choudhury RP, Aouadi M. Extracellular vesicles in metabolic disease. Diabetologia. (2019) 62:2179–87. doi: 10.1007/s00125-019-05014-5

CrossRef Full Text | Google Scholar

119. Veziroglu EM, Mias GI. Characterizing extracellular vesicles and their diverse RNA contents. Front Genet. (2020) 11:700. doi: 10.3389/fgene.2020.00700

PubMed Abstract | CrossRef Full Text | Google Scholar

120. Doyle LM, Wang MZ. Overview of extracellular vesicles, their origin, composition, purpose, and methods for exosome isolation and analysis. Cells. (2019) 8:727. doi: 10.3390/cells8070727

PubMed Abstract | CrossRef Full Text | Google Scholar

121. Willms E, Cabañas C, Mäger I, Wood MJA, Vader P. Extracellular vesicle heterogeneity: subpopulations, isolation techniques, and diverse functions in cancer progression. Front Immunol. (2018) 9:738. doi: 10.3389/fimmu.2018.00738

PubMed Abstract | CrossRef Full Text | Google Scholar

122. van Bergenhenegouwen J, Kraneveld AD, Rutten L, Kettelarij N, Garssen J, Vos AP. Extracellular vesicles modulate host-microbe responses by altering TLR2 activity and phagocytosis. PLoS ONE. (2014) 9:e89121. doi: 10.1371/journal.pone.0089121

PubMed Abstract | CrossRef Full Text | Google Scholar

123. Kocak P, Kala EY, Gunes M, Unsal N, Yilmaz H, Metin B, et al. Edible plant-derived exosomes and their therapeutic applicatons. J Biomed Imag Bioeng. (2020) 4:130–5.

124. Cui Y, Gao J, He Y, Jiang L. Plant extracellular vesicles. Protoplasma. (2020) 257:3–12. doi: 10.1007/s00709-019-01435-6

CrossRef Full Text | Google Scholar

125. Teng Y, Ren Y, Sayed M, Hu X, Lei C, Kumar A, et al. Plant-derived exosomal microRNAs shape the gut microbiota. Cell Host Microbe. (2018) 24:637–52.e8. doi: 10.1016/j.chom.2018.10.001

PubMed Abstract | CrossRef Full Text | Google Scholar

126. Rutter BD, Innes RW. Extracellular vesicles as key mediators of plant–microbe interactions. Curr Opin Plant Biol. (2018) 44:16–22. doi: 10.1016/j.pbi.2018.01.008

PubMed Abstract | CrossRef Full Text | Google Scholar

127. Cottrill KA, Chan SY. Diet-derived microRNAs: separating the dream from reality. microRNA Diagnostics Ther. (2014) 1:46–57. doi: 10.2478/micrnat-2014-0001

CrossRef Full Text | Google Scholar

128. Rome S. Biological properties of plant-derived extracellular vesicles. Food Funct. (2019) 10:529–38. doi: 10.1039/C8FO02295J

PubMed Abstract | CrossRef Full Text | Google Scholar

129. Iravani S, Varma RS. Plant-derived edible nanoparticles and miRNAs: emerging frontier for therapeutics and targeted drug-delivery. ACS Sustain Chem Eng. (2019) 7:8055–69. doi: 10.1021/acssuschemeng.9b00954

CrossRef Full Text | Google Scholar

130. Zhang M, Merlin D. Nanoparticle-based oral drug delivery systems targeting the colon for treatment of ulcerative colitis. Inflamm Bowel Dis. (2018) 24:1401–15. doi: 10.1093/ibd/izy123

PubMed Abstract | CrossRef Full Text | Google Scholar

131. Zhang M, Viennois E, Xu C, Merlin D. Plant derived edible nanoparticles as a new therapeutic approach against diseases. Tissue Barriers. (2016) 4:e1134415. doi: 10.1080/21688370.2015.1134415

PubMed Abstract | CrossRef Full Text | Google Scholar

132. Xiao J, Feng S, Wang X, Long K, Luo Y, Wang Y, et al. Identification of exosome-like nanoparticle-derived microRNAs from 11 edible fruits and vegetables. PeerJ. (2018) 6:e5186. doi: 10.7717/peerj.5186

PubMed Abstract | CrossRef Full Text | Google Scholar

133. Baldrich P, Rutter BD, Karimi HZ, Podicheti R, Meyers BC, Innes RW. Plant extracellular vesicles contain diverse small RNA species and are enriched in 10- to 17-nucleotide “tiny” RNAs. Plant Cell. (2019) 31:315–24. doi: 10.1105/tpc.18.00872

PubMed Abstract | CrossRef Full Text | Google Scholar

134. Philip A, Ferro VA, Tate RJ. Determination of the potential bioavailability of plant microRNAs using a simulated human digestion process. Mol Nutr Food Res. (2015) 59:1962–72. doi: 10.1002/mnfr.201500137

PubMed Abstract | CrossRef Full Text | Google Scholar

135. Chassard C, Delmas E, Robert C, Lawson PA, Bernalier-Donadille A. Ruminococcus champanellensis sp. nov., a cellulose-degrading bacterium from human gut microbiota. Int J Syst Evol Microbiol. (2012) 62:138–43. doi: 10.1099/ijs.0.027375-0

PubMed Abstract | CrossRef Full Text | Google Scholar

136. Chassard C, Delmas E, Robert C, Bernalier-Donadille A. The cellulose-degrading microbial community of the human gut varies according to the presence or absence of methanogens. FEMS Microbiol Ecol. (2010) 74:205–13. doi: 10.1111/j.1574-6941.2010.00941.x

PubMed Abstract | CrossRef Full Text | Google Scholar

137. Flint HJ, Scott KP, Duncan SH, Louis P, Forano E. Microbial degradation of complex carbohydrates in the gut. Gut Microbes. (2012) 3:289–306. doi: 10.4161/gmic.19897

PubMed Abstract | CrossRef Full Text | Google Scholar

138. Hong PY, Iakiviak M, Dodd D, Zhang M, Mackie RI, Cann I. Two new xylanases with different substrate specificities from the human gut bacterium Bacteroides intestinalis DSM 17393. Appl Environ Microbiol. (2014) 80:2084–93. doi: 10.1128/AEM.03176-13

PubMed Abstract | CrossRef Full Text | Google Scholar

139. Dongowski G, Lorenz A, Anger H. Degradation of pectins with different degrees of esterification by Bacteroides thetaiotaomicron isolated from human gut flora. Appl Environ Microbiol. (2000) 66:1321–7. doi: 10.1128/AEM.66.4.1321-1327.2000

PubMed Abstract | CrossRef Full Text | Google Scholar

140. Parada J, Aguilera JM. Food microstructure affects the bioavailability of several nutrients. J Food Sci. (2007) 72:R21–32. doi: 10.1111/j.1750-3841.2007.00274.x

PubMed Abstract | CrossRef Full Text | Google Scholar

141. Hansen NW, Sams A. The microbiotic highway to health-new perspective on food structure, gut microbiota, and host inflammation. Nutrients. (2018) 10:1590. doi: 10.3390/nu10111590

PubMed Abstract | CrossRef Full Text | Google Scholar

142. Kvit K, Kharchenko V. Role of gut microbiota in lipid metabolism. Asian J Pharm Clin Res. (2018) 11:4. doi: 10.22159/ajpcr.2018.v11i4.23953

CrossRef Full Text | Google Scholar

143. Munsch-Alatossava P, Kakela R, Ibarra D, Youbi-Idrissi M, Alatossava T. Phospholipolysis caused by different types of bacterial phospholipases during cold storage of bovine raw milk is prevented by N2 gas flushing. Front Microbiol. (2018) 9:1307. doi: 10.3389/fmicb.2018.01307

PubMed Abstract | CrossRef Full Text | Google Scholar

144. Skotland T, Sagini K, Sandvig K, Llorente A. An emerging focus on lipids in extracellular vesicles. Adv Drug Deliv Rev. (2020) 159:308–21. doi: 10.1016/j.addr.2020.03.002

PubMed Abstract | CrossRef Full Text | Google Scholar

145. Santiago-Rodriguez TM, Cano R, Jimenez-Flores R. Potential applications of metagenomics to assess the biological effects of food structure and function. Food Funct. (2016) 7:4160–9. doi: 10.1039/C6FO00317F

PubMed Abstract | CrossRef Full Text | Google Scholar

146. Ortega-Anaya J, Jimenez-Flores R. Symposium review: the relevance of bovine milk phospholipids in human nutrition-Evidence of the effect on infant gut and brain development. J Dairy Sci. (2019) 102:2738–48. doi: 10.3168/jds.2018-15342

PubMed Abstract | CrossRef Full Text | Google Scholar

147. Wang B, Zhuang X, Deng ZB, Jiang H, Mu J, Wang Q, et al. Targeted drug delivery to intestinal macrophages by bioactive nanovesicles released from grapefruit. Mol Ther. (2014) 22:522–34. doi: 10.1038/mt.2013.190

PubMed Abstract | CrossRef Full Text | Google Scholar

148. Liang H, Kidder K, Liu Y. Extracellular microRNAs initiate immunostimulation via activating toll-like receptor signaling pathways. ExRNA. (2019) 1:9. doi: 10.1186/s41544-019-0009-x

CrossRef Full Text | Google Scholar

149. Cavalieri D, Rizzetto L, Tocci N, Rivero D, Asquini E, Si-Ammour A, et al. Plant microRNAs as novel immunomodulatory agents. Sci Rep. (2016) 6:25761. doi: 10.1038/srep25761

PubMed Abstract | CrossRef Full Text | Google Scholar

150. Ursell LK, Clemente JC, Rideout JR, Gevers D, Caporaso JG, Knight R. The interpersonal and intrapersonal diversity of human-associated microbiota in key body sites. J Allergy Clin Immunol. (2012) 129:1204–8. doi: 10.1016/j.jaci.2012.03.010

PubMed Abstract | CrossRef Full Text | Google Scholar

151. Ahmad A, Yang W, Chen G, Shafiq M, Javed S, Ali Zaidi SS, et al. Analysis of gut microbiota of obese individuals with type 2 diabetes and healthy individuals. PLoS ONE. (2019) 14:e0226372. doi: 10.1371/journal.pone.0226372

PubMed Abstract | CrossRef Full Text | Google Scholar

152. Cavallini A, Minervini F, Garbetta A, Lippolis C, Scamarcio G, Di Franco C, et al. High degradation and no bioavailability of artichoke miRNAs assessed using an in vitro digestion/Caco-2 cell model. Nutr Res. (2018) 60:68–76. doi: 10.1016/j.nutres.2018.08.007

PubMed Abstract | CrossRef Full Text | Google Scholar

153. Li M, Chen T, Wang R, Luo JY, He JJ, Ye RS, et al. Plant MIR156 regulates intestinal growth in mammals by targeting the Wnt/beta-catenin pathway. Am J Physiol Cell Physiol. (2019) 317:C434–48. doi: 10.1152/ajpcell.00030.2019

PubMed Abstract | CrossRef Full Text | Google Scholar

154. Mallory AC, Elmayan T, Vaucheret H. MicroRNA maturation and action–the expanding roles of ARGONAUTEs. Curr Opin Plant Biol. (2008) 11:560–6. doi: 10.1016/j.pbi.2008.06.008

PubMed Abstract | CrossRef Full Text | Google Scholar

155. Vaucheret H, Mallory AC, Bartel DP. AGO1 homeostasis entails coexpression of MIR168 and AGO1 and preferential stabilization of miR168 by AGO1. Mol Cell. (2006) 22:129–36. doi: 10.1016/j.molcel.2006.03.011

PubMed Abstract | CrossRef Full Text | Google Scholar

156. Rahimi Ghiasi M, Rahimi E, Amirkhani Z, Salehi R. Leucine-rich repeat-containing G-protein coupled receptor 5 gene overexpression of the rat small intestinal progenitor cells in response to orally administered grape exosome-like nanovesicles. Adv Biomed Res. (2018) 7:125. doi: 10.4103/abr.abr_114_18

PubMed Abstract | CrossRef Full Text | Google Scholar

157. Zhang M, Wang X, Han MK, Collins JF, Merlin D. Oral administration of ginger-derived nanolipids loaded with siRNA as a novel approach for efficient siRNA drug delivery to treat ulcerative colitis. Nanomedicine. (2017) 12:1927–43. doi: 10.2217/nnm-2017-0196

PubMed Abstract | CrossRef Full Text | Google Scholar

158. Sundaram GM. Dietary non-coding RNAs from plants: fairy tale or treasure? Noncoding RNA Res. (2019) 4:63–8. doi: 10.1016/j.ncrna.2019.02.002

PubMed Abstract | CrossRef Full Text | Google Scholar

159. Wang M, Thomas N, Jin H. Cross-kingdom RNA trafficking and environmental RNAi for powerful innovative pre- and post-harvest plant protection. Curr Opin Plant Biol. (2017) 38:133–41. doi: 10.1016/j.pbi.2017.05.003

PubMed Abstract | CrossRef Full Text | Google Scholar

160. Bundó M, Campo S, San Segundo B. Role of microRNAs in Plant–Fungus Interactions. In: Miguel C, Dalmay T, Chaves I, editors. Plant microRNAs. Concepts and Strategies in Plant Sciences. Cham: Springer (2020). p. 199–220.

Google Scholar

161. Hudzik C, Hou Y, Ma W, Axtell MJ. Exchange of small regulatory RNAs between plants and their pests. Plant Physiol. (2020) 182:51–62. doi: 10.1104/pp.19.00931

PubMed Abstract | CrossRef Full Text | Google Scholar

162. Cai Q, Qiao L, Wang M, He B, Lin FM, Palmquist J, et al. Plants send small RNAs in extracellular vesicles to fungal pathogen to silence virulence genes. Science. (2018) 360:1126–9. doi: 10.1126/science.aar4142

PubMed Abstract | CrossRef Full Text | Google Scholar

163. Singla-Rastogi M, Charvin M, Thiebeauld O, Perez-Quintero A, Ravet A, Emidio-Fortunato A, et al. Plant small RNA species direct gene silencing in pathogenic bacteria as well as disease protection. biorxiv. (2019). doi: 10.1101/863902

CrossRef Full Text | Google Scholar

164. Zhou F, Paz HA, Sadri M, Cui J, Kachman SD, Fernando SC, et al. Dietary bovine milk exosomes elicit changes in bacterial communities in C57BL/6 mice. Am J Physiol Gastrointest Liver Physiol. (2019) 317:G618–24. doi: 10.1152/ajpgi.00160.2019

PubMed Abstract | CrossRef Full Text | Google Scholar

165. Fujita D, Arai T, Komori H, Shirasaki Y, Wakayama T, Nakanishi T, et al. Apple-derived nanoparticles modulate expression of organic-anion-transporting polypeptide (OATP) 2B1 in Caco-2 cells. Mol Pharm. (2018) 15:5772–80. doi: 10.1021/acs.molpharmaceut.8b00921

PubMed Abstract | CrossRef Full Text | Google Scholar

166. Li M, Chen T, He JJ, Wu JH, Luo JY, Ye RS, et al. Plant MIR167e-5p Inhibits Enterocyte Proliferation by Targeting beta-Catenin. Cells. (2019) 8:1385. doi: 10.3390/cells8111385

PubMed Abstract | CrossRef Full Text | Google Scholar

167. Fevr T, Robine S, Louvard D, Huelsken J. Wnt/beta-catenin is essential for intestinal homeostasis and maintenance of intestinal stem cells. Mol Cell Biol. (2007) 27:7551–9. doi: 10.1128/MCB.01034-07

PubMed Abstract | CrossRef Full Text | Google Scholar

168. Cadigan KM. Wnt-beta-catenin signaling. Curr Biol. (2008) 18:R943–7. doi: 10.1016/j.cub.2008.08.017

CrossRef Full Text | Google Scholar

169. Li B, Lee C, Cadete M, Zhu H, Koike Y, Hock A, et al. Impaired Wnt/beta-catenin pathway leads to dysfunction of intestinal regeneration during necrotizing enterocolitis. Cell Death Dis. (2019) 10:743. doi: 10.1038/s41419-019-1987-1

PubMed Abstract | CrossRef Full Text | Google Scholar

170. Zhu L, Lu X, Liu L, Voglmeir J, Zhong X, Yu Q. Akkermansia muciniphila protects intestinal mucosa from damage caused by S. pullorum by initiating proliferation of intestinal epithelium. Vet Res. (2020) 51:34. doi: 10.1186/s13567-020-00755-3

PubMed Abstract | CrossRef Full Text | Google Scholar

171. Zhou JY, Lin HL, Wang Z, Zhang SW, Huang DG, Gao CQ, et al. Zinc L-Aspartate enhances intestinal stem cell activity to protect the integrity of the intestinal mucosa against deoxynivalenol through activation of the Wnt/beta-catenin signaling pathway. Environ Pollut. (2020) 262:114290. doi: 10.1016/j.envpol.2020.114290

PubMed Abstract | CrossRef Full Text | Google Scholar

172. Chokshi NK, Guner YS, Hunter CJ, Upperman JS, Grishin A, Ford HR. The role of nitric oxide in intestinal epithelial injury and restitution in neonatal necrotizing enterocolitis. Semin Perinatol. (2008) 32:92–9. doi: 10.1053/j.semperi.2008.01.002

PubMed Abstract | CrossRef Full Text | Google Scholar

173. Williams JM, Duckworth CA, Burkitt MD, Watson AJ, Campbell BJ, Pritchard DM. Epithelial cell shedding and barrier function: a matter of life and death at the small intestinal villus tip. Vet Pathol. (2015) 52:445–55. doi: 10.1177/0300985814559404

PubMed Abstract | CrossRef Full Text | Google Scholar

174. He Y, Yuan X, Zuo H, Sun Y, Feng A. Berberine exerts a protective effect on gut-vascular barrier via the modulation of the Wnt/beta-catenin signaling pathway during sepsis. Cell Physiol Biochem. (2018) 49:1342–51. doi: 10.1159/000493412

PubMed Abstract | CrossRef Full Text | Google Scholar

175. Miwa N, Furuse M, Tsukita S, Niikawa N, Nakamura Y, Furukawa Y. Involvement of claudin-1 in the beta-catenin/Tcf signaling pathway and its frequent upregulation in human colorectal cancers. Oncol Res. (2001) 12:469–76. doi: 10.3727/096504001108747477

PubMed Abstract | CrossRef Full Text | Google Scholar

176. Mankertz J, Hillenbrand B, Tavalali S, Huber O, Fromm M, Schulzke JD. Functional crosstalk between Wnt signaling and Cdx-related transcriptional activation in the regulation of the claudin-2 promoter activity. Biochem Biophys Res Commun. (2004) 314:1001–7. doi: 10.1016/j.bbrc.2003.12.185

PubMed Abstract | CrossRef Full Text | Google Scholar

177. Yang K, Zhu J, Wu J, Zhong Y, Shen X, Petrov B, et al. Maternal vitamin D deficiency increases intestinal permeability and programs Wnt/β-catenin pathway in BALB/C mice. JPEN J Parenter Enteral Nutr. (2020) 45:102–14. doi: 10.1002/jpen.1820

PubMed Abstract | CrossRef Full Text | Google Scholar

178. Chen X, Zhou Y, Yu J. Exosome-like nanoparticles from ginger rhizomes inhibited NLRP3 inflammasome activation. Mol Pharm. (2019) 16:2690–9. doi: 10.1021/acs.molpharmaceut.9b00246

PubMed Abstract | CrossRef Full Text | Google Scholar

179. Kurowski J, Liu F, Wang P, Bu H-F, Geng H, Wang X, et al. 71 activation of NLRP3 inflammasome increases intestinal epithelial permeability in vitro. Gastroenterology. (2015)148:S-20. doi: 10.1016/S0016-5085(15)30071-8

CrossRef Full Text | Google Scholar

180. Rainone V, Schneider L, Saulle I, Ricci C, Biasin M, Al-Daghri NM, et al. Upregulation of inflammasome activity and increased gut permeability are associated with obesity in children and adolescents. Int J Obes. (2016) 40:1026–33. doi: 10.1038/ijo.2016.26

PubMed Abstract | CrossRef Full Text | Google Scholar

181. Cao M, Yan H, Han X, Weng L, Wei Q, Sun X, et al. Ginseng-derived nanoparticles alter macrophage polarization to inhibit melanoma growth. J Immunother Cancer. (2019) 7:326. doi: 10.1186/s40425-019-0817-4

PubMed Abstract | CrossRef Full Text | Google Scholar

182. Suzuki T, Yoshinaga N, Tanabe S. Interleukin-6 (IL-6) regulates claudin-2 expression and tight junction permeability in intestinal epithelium. J Biol Chem. (2011) 286:31263–71. doi: 10.1074/jbc.M111.238147

PubMed Abstract | CrossRef Full Text | Google Scholar

183. Morhardt TL, Hayashi A, Ochi T, Quiros M, Kitamoto S, Nagao-Kitamoto H, et al. IL-10 produced by macrophages regulates epithelial integrity in the small intestine. Sci Rep. (2019) 9:1223. doi: 10.1038/s41598-018-38125-x

PubMed Abstract | CrossRef Full Text | Google Scholar

184. Wang Y, Mumm JB, Herbst R, Kolbeck R, Wang Y. IL-22 increases permeability of intestinal epithelial tight junctions by enhancing claudin-2 expression. J Immunol. (2017) 199:3316–25. doi: 10.4049/jimmunol.1700152

PubMed Abstract | CrossRef Full Text | Google Scholar

185. Zhang L, Zhang Z, Liu B, Jin Y, Tian Y, Xin Y, et al. The protective effect of heme oxygenase-1 against intestinal barrier dysfunction in cholestatic liver injury is associated with NF-kappaB inhibition. Mol Med. (2017) 23:215–24. doi: 10.2119/molmed.2017.00078

PubMed Abstract | CrossRef Full Text | Google Scholar

186. Wen Z, Liu W, Li X, Chen W, Liu Z, Wen J, et al. A protective role of the NRF2-keap1 pathway in maintaining intestinal barrier function. Oxid Med Cell Longev. (2019) 2019:1759149. doi: 10.1155/2019/1759149

PubMed Abstract | CrossRef Full Text | Google Scholar

187. Al-Sadi R, Guo S, Ye D, Rawat M, Ma TY. TNF-alpha modulation of intestinal tight junction permeability is mediated by NIK/IKK-alpha axis activation of the canonical NF-kappaB pathway. Am J Pathol. (2016) 186:1151–65. doi: 10.1016/j.ajpath.2015.12.016

PubMed Abstract | CrossRef Full Text | Google Scholar

188. Al-Sadi R, Ye D, Said HM, Ma TY. IL-1beta-induced increase in intestinal epithelial tight junction permeability is mediated by MEKK-1 activation of canonical NF-kappaB pathway. Am J Pathol. (2010) 177:2310–22. doi: 10.2353/ajpath.2010.100371

PubMed Abstract | CrossRef Full Text | Google Scholar

189. Deng Z, Rong Y, Teng Y, Mu J, Zhuang X, Tseng M, et al. Broccoli-derived nanoparticle inhibits mouse colitis by activating dendritic cell AMP-activated protein kinase. Mol Ther. (2017) 25:1641–54. doi: 10.1016/j.ymthe.2017.01.025

PubMed Abstract | CrossRef Full Text | Google Scholar

190. Tong L, Hao H, Zhang X, Zhang Z, Lv Y, Zhang L, et al. Oral administration of bovine milk-derived extracellular vesicles alters the gut microbiota and enhances intestinal immunity in mice. Mol Nutr Food Res. (2020) 64:e1901251. doi: 10.1002/mnfr.201901251

PubMed Abstract | CrossRef Full Text | Google Scholar

191. Lukasik A, Brzozowska I, Zielenkiewicz U, Zielenkiewicz P. Detection of plant miRNAs abundance in human breast milk. Int J Mol Sci. (2017) 19:37. doi: 10.3390/ijms19010037

PubMed Abstract | CrossRef Full Text | Google Scholar

192. Lukasik A, Zielenkiewicz P. In silico identification of plant miRNAs in mammalian breast milk exosomes–a small step forward? PLoS ONE. (2014) 9:e99963. doi: 10.1371/journal.pone.0099963

CrossRef Full Text | Google Scholar

193. Stephen BJ, Pareek N, Saeed M, Kausar MA, Rahman S, Datta M. Xeno-miRNA in maternal-infant immune crosstalk: an aid to disease alleviation. Front Immunol. (2020) 11:404. doi: 10.3389/fimmu.2020.00404

PubMed Abstract | CrossRef Full Text | Google Scholar

194. Mirza AH, Kaur S, Nielsen LB, Storling J, Yarani R, Roursgaard M, et al. Breast milk-derived extracellular vesicles enriched in exosomes from mothers with type 1 diabetes contain aberrant levels of microRNAs. Front Immunol. (2019) 10:2543. doi: 10.3389/fimmu.2019.02543

PubMed Abstract | CrossRef Full Text | Google Scholar

195. Zhou Q, Li M, Wang X, Li Q, Wang T, Zhu Q, et al. Immune-related microRNAs are abundant in breast milk exosomes. Int J Biol Sci. (2012) 8:118–23. doi: 10.7150/ijbs.8.118

PubMed Abstract | CrossRef Full Text | Google Scholar

196. Izumi H, Tsuda M, Sato Y, Kosaka N, Ochiya T, Iwamoto H, et al. Bovine milk exosomes contain microRNA and mRNA and are taken up by human macrophages. J Dairy Sci. (2015) 98:2920–33. doi: 10.3168/jds.2014-9076

PubMed Abstract | CrossRef Full Text | Google Scholar

197. Melnik BC, Schmitz G. MicroRNAs: milk's epigenetic regulators. Best Pract Res Clin Endocrinol Metab. (2017) 31:427–42. doi: 10.1016/j.beem.2017.10.003

PubMed Abstract | CrossRef Full Text | Google Scholar

198. Zhang H, Li Y, Liu Y, Liu H, Wang H, Jin W, et al. Role of plant microRNA in cross-species regulatory networks of humans. BMC Syst Biol. (2016) 10:60. doi: 10.1186/s12918-016-0292-1

PubMed Abstract | CrossRef Full Text | Google Scholar

199. Aquilano K, Ceci V, Gismondi A, De Stefano S, Iacovelli F, Faraonio R, et al. Adipocyte metabolism is improved by TNF receptor-targeting small RNAs identified from dried nuts. Commun Biol. (2019) 2:317. doi: 10.1038/s42003-019-0563-7

PubMed Abstract | CrossRef Full Text

200. Winer DA, Luck H, Tsai S, Winer S. The intestinal immune system in obesity and insulin resistance. Cell Metab. (2016) 23:413–26. doi: 10.1016/j.cmet.2016.01.003

PubMed Abstract | CrossRef Full Text | Google Scholar

201. Ahmad R, Rah B, Bastola D, Dhawan P, Singh AB. Obesity-induces organ and tissue specific tight junction restructuring and barrier deregulation by claudin switching. Sci Rep. (2017) 7:5125. doi: 10.1038/s41598-017-04989-8

PubMed Abstract | CrossRef Full Text | Google Scholar

202. Nouri M, Bredberg A, Westrom B, Lavasani S. Intestinal barrier dysfunction develops at the onset of experimental autoimmune encephalomyelitis, and can be induced by adoptive transfer of auto-reactive T cells. PLoS ONE. (2014) 9:e106335. doi: 10.1371/journal.pone.0106335

PubMed Abstract | CrossRef Full Text | Google Scholar

203. Silva MA. Intestinal dendritic cells and epithelial barrier dysfunction in Crohn's disease. Inflamm Bowel Dis. (2009) 15:436–53. doi: 10.1002/ibd.20660

PubMed Abstract | CrossRef Full Text | Google Scholar

204. Romano M. Gut microbiota as a trigger of accelerated directional adaptive evolution: acquisition of herbivory in the context of extracellular vesicles, microRNAs and inter-kingdom crosstalk. Front Microbiol. (2017) 8:721. doi: 10.3389/fmicb.2017.00721

PubMed Abstract | CrossRef Full Text | Google Scholar

205. Youngblut ND, Reischer GH, Walters W, Schuster N, Walzer C, Stalder G, et al. Host diet and evolutionary history explain different aspects of gut microbiome diversity among vertebrate clades. Nat Commun. (2019) 10:2200. doi: 10.1038/s41467-019-10191-3

PubMed Abstract | CrossRef Full Text | Google Scholar

206. Faith JJ, McNulty NP, Rey FE, Gordon JI. Predicting a human gut microbiota's response to diet in gnotobiotic mice. Science. (2011) 333:101–4. doi: 10.1126/science.1206025

PubMed Abstract | CrossRef Full Text | Google Scholar

207. Senghor B, Sokhna C, Ruimy R, Lagier J-C. Gut microbiota diversity according to dietary habits and geographical provenance. Hum Microbiome J. (2018) 7–8:1–9. doi: 10.1016/j.humic.2018.01.001

CrossRef Full Text | Google Scholar

208. Di Rienzi SC, Britton RA. Adaptation of the gut microbiota to modern dietary sugars and sweeteners. Adv Nutr. (2020) 11:616–29. doi: 10.1093/advances/nmz118

PubMed Abstract | CrossRef Full Text | Google Scholar